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• Initiating and consolidating the process of building the cohort and monitoring the 
project recruitment and follow-up. This included clinical diagnosis and 
management, and setting up the mobile primary health care and STD clinic.
• Continuous in-service training of staff, including clinical and research 
methodology training for the project physician from the University of Nairobi, Dr 
J P Rakwar.
• Data management (in addition to most of the data entry in the first year).
• Liaison with the laboratory and contribution to project laboratory direction, with 
Dr K Mandaliya, the Coast Provincial Pathologist. Ms Bhavna Chohan was the 
laboratory manager with whom the author worked on a day-to-day basis.
• Analysis of the data: exception to this was the time-trend modeling, in which the 
author was assisted by Dr B Richardson, biostatistician and assistant research 
professor from the University of Washington. Dr N Nagelkerke of the University 
of Manitoba (now Erasmus University, Netherlands) provided statistical advice on 
the urethral infection study.
• Interpretation of the results and preparation for publication and presentation. This 
included wiiting the papers, with editorial review from Professor J K Ki’eiss for 
the prospective cohort and vaccine acceptability study, and Dr S Moses for the 
cross-sectional urethral infection study.
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Abstract
A cohort of HIV-1 seronegative male trucking company workers was 
established in the Kenyan coastal city of Mombasa, for the purposes of preparing 
them for HIV-1 preventive vaccine trials. The cohort was one of only tliree 
prospective male cohorts which have published data on heterosexual HIV-1 
acquisition in sub-Saharan Africa, the continent most affected by this pandemic.
HIV-1 seroincidence was measured and correlates of HIV-1 acquisition, including 
other STDs, were examined. Results of almost thi’ee year’s of follow-up, and data on 
anticipated acceptance of the conditions of an HIV-1 vaccine trial are presented.
• The baseline seroprevalence for antibodies to HIV-1 was 17% and the prevalence 
of active syphilis was 4.5%.
• HIV-1 seroincidence was 4.0% per annum in 990 person years of follow-up. 
Multivariate Hazard analysis revealed a strong association between HIV-1 
acquisition and occupation of driver or assistant (HR 4.0, 95% Cl: 2.1-7.9), any 
sex with a par’tner other than a spouse (HR 4.2, 95% Cl: 1.3-13.6), and a trend 
towards higher incidence with uncircumcised status (HR 2.0, 95% Cl: 0.9-4.6).
No association between STD and HIV-1 acquisition was found with an observed 
incidence of symptomatic gonococcal and non-gonococcal methral discharge of 
18.2% per annum, and 4.3% per annum for genital ulcer disease.
• There were highly significant declines in extramarital sexual contacts from 50% to 
40% in three month follow-up time blocks (p<0.001), and sex worker contacts 
from 12% to 6% (p=0.001), in a time trends analysis which included 494 person- 
yeai’s of follow-up. No significant change in condom use was recorded over time.
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Consistent (100%) condom use remained at approximately 30% of men engaging 
in extramarital sex with a partner other than a spouse.
• Highly significant declines in the incidence of observed and reported sexually 
transmitted diseases were measured over the course of follow-up (p<0.001) in the 
first 494 person-years of follow-up. In the absence of data from the general 
population, it is not possible to attribute these declines to the behavioural and 
treatment interventions of the project, but it does document that the climate is right 
for behaviour change, and decrease in STD acquisition, in men in this setting.
• Prevalence of symptomatic and asymptomatic urethi'al infections {N gonorrhoeae, 
C trachomatis, or T vaginalis) was 11.5% in a cross-sectional study which 
included HIV-1 seropositive men, following the documented decline in 
symptomatic STDs. Over two thirds of infections were asymptomatic. The 
leucocyte esterase dipstick (LED) urine screening test for urethral inflammation 
had a sensitivity of 55% and a specificity of 82%, in asymptomatic men. The 
LED test was the most accurate predictor of asymptomatic urethral infection. Risk 
assessment on the basis of demographic and behavioural characteristics did not 
prove useful. T vaginalis was the most common uietlnal infection and was 
associated with older age.
• Eighty six per cent of 201 HIV-1 seronegative men interviewed in a vaccine 
acceptability survey stated that they felt at personal risk of HIV infection, and 
84% of men declared interest in participation in an LIIV preventive vaccine trial. 
Llowever, 17% of men stated that they would increase risk behaviour if they 
participated in an HIV vaccine trial.
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Thesis Overview
The studies outlined in this thesis were initiated following a call for proposals 
from the United States National Institutes of Health (NIH) in 1992, in order to 
establish international sites for trials o f preventive HIV vaccines. Cohorts at high risk 
of HIV infection were to be established in nine countries in Africa, Asia, and the 
Americas, in addition to US domestic cohorts. The research proposal sponsored by 
the NIH was "High Risk Cohorts in Kenya: Prostitutes and Truckdrivers", with the 
investigations to be carried out in a field site to be established in the coastal city of 
Mombasa.
The author, as field director, had overall administrative responsibility for 
establishment and maintenance of the field site. The studies covered in this thesis are 
those for which he had primary scientific responsibility for development, 
implementation and reporting during his tenure. The aims of these studies were:
1. To characterise a heterosexual, HIV-1 seronegative male cohort, at high risk of 
HIV-1 infection, for the purposes of inclusion in HIV-1 preventive vaccine trials.
2. To measure HIV-1 seroincidence and assess the following potential coii’elates of 
HIV-1 acquisition: male circumcision status, other STDs, sexual risk behaviour, 
and occupational travel.
3. To determine the prevalence of symptomatic and asymptomatic curable uretliral 
infections in male trucking workers and examine strategies for control.
4. To document the potential acceptability of an HIV preventive vaccine trial in the 
cohort of male trucking company workers.
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Background
The WHO Collaborative Centre for STD Research has existed at the 
Department of Medical Microbiology of the University of Nairobi, Kenyatta National 
Hospital Campus, since 1981. The first collaborators were the University of Nairobi 
and the University of Manitoba (Professors Frank Plummer and Allan Ronald). These 
institutions were joined by the Universities of Washington (Professor King Holmes), 
and the Institute of Tropical Medicine of Antwerp (Professor Peter Piot), in 1985. 
Research sites were established at Nairobi City Council special treatment (STD) 
clinic, and at a community site in the Pumwani slum, where many home-based female 
sex workers (FSWs) live.
There have been many active Kenyan research partners, the most prominent 
being Professor Ndinya-Achola and Dr Bwayo. It was Dr Bwayo’s work with the 
long-distance truck drivers at the Athi River Weigh Station , on the Mombasa Road 
25 km east of Nairobi, which was instrumental in the formulation of many of the 
research questions which we attempted to address in Mombasa [1].
Mombasa is a city of approximately half a million people and a major east 
African sea port. Trucking companies which service trade routes throughout east- 
central Africa have terminals in Mombasa where trucks are maintained and loads 
assigned to drivers. The drivers and their assistants stayed in Mombasa for several 
days during the “turn-around” period. This provided potentially regular access to the 
men, a problem which could not be overcome at Athi River, where the men remained 
for a few hours only.
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A feature which potentially played a role in the importance of the transport 
industry in the HIV epidemic is the industrialisation process which is gaining pace in 
Kenya, driven in part by the economic Structural Adjustment Programmes (SAPs) of 
the World Bank and International Monetary Fund. These SAPs have inadvertently 
fuelled the HIV-1 epidemic by shifting emphasis from food to cash crops, thereby 
making subsistence farming less viable and accelerating rural to urban migration, 
improving roads and communications infrastructure, and decreasing expenditure on 
health and social services [2]. A cycle of uncontrolled and um egulated development 
has ensued, with influx of male migrant workers into the large towns, including 
Mombasa.
In the current pandemic, more emphasis has been placed on changing the 
behaviour of women for the following reasons: high-risk groups are easier to identify 
and access, women are more receptive to health messages, and more amenable to 
community activities. What is clear, however, is that the power lies with the male 
when it comes to sexual decision making. As long as there are poor women and 
gender inequality, the ability of women to effect behaviour change, such as consistent 
condom use, will be limited [3].
While there are now effective cures for many STDs, access to treatment in 
developing countries is often difficult, and conditions which prevailed in Victorian 
London are mimicked in modern African cities, with private wealth, public squalor, 
and rampant prostitution. The lifestyle of men who leave their tribal homes to come 
to work in the industrial centres is Spartan and often brutal. They tend to live in
16
bachelor groups in low-quality accommodation. There is a need for greater 
understanding of the determinants of male sexual behaviour in these conditions.
Ganjoni Clinic in Mombasa, the operational centre of the research in this 
thesis, is also of historical interest in STD control. In the 1940's and 50's, Mombasa 
was the sea port where the British colonial administration off-loaded their troops to 
police their commercial interests in east Africa. A thr iving sex trade grew up around 
these troops, and the colonial administration found that it was losing soldiers' work 
time because of STDs. For this reason, a system of registration of female sex workers 
was set in place.
The advent of mass tourism to Mombasa in the last twenty years has been 
another factor which has had impact on commercial sex. While military and merchant 
navy ships from all over the world have traditionally docked at Mombasa, their anival 
was sporadic and women would come from up-country to service the sailors. It was 
quite usual for buses to be hired by groups of women from Nairobi and the west of 
Kenya, to take them down to the coast, when the "fleet" was in port. The year-round 
presence of tourists with large amounts of money to spend has slowed this tidal flow 
of sex workers to a trickle, as many more are now resident in the town, and the 
differential increase in business when the ships come in has decreased.
Women who may initially have come to Mombasa to service the night-club 
sex trade, become bar workers as they become older and a less valuable commercial 
commodity, and sex with customers becomes a way of making ends meet [4]. These 
women ar e often sexual partners of trucking and other itinerant workers, and this point 
will be discussed in the appropriate sections.
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It was planned that the prospective cohort of HIV-1 seronegative male long­
distance truck drivers would form a closed cohort, which would both be followed at 
Ganjoni clinic. In this way, HIV-1 seroincidence would be measured and the subjects 
prepared for trials of a candidate HIV-1 preventive vaccine.
In a closed cohort design, a pre-determined number of subjects are recruited 
over a short period of time, and followed for a fixed period of time [5]. New subjects 
are not recruited after the recruitment period, and there is an expectation of a degree of 
cohort attrition due to migration, withdrawal and death. In the case of the truck 
drivers study, it was estimated that 750 seronegative men would be required.
This calculation was based on the assumptions that there would be an annual 
HIV-1 seroconversion rate of 10%, follow-up of 18 months, and a 20% loss to follow- 
up. This would allow 296 subjects in each arm of a randomised, double-blind, 
placebo-controlled vaccine trial, with 90% power to show a significant difference 
(alpha error 0.05) if vaccine efficacy was 50%. The first tln ee months of the study 
were to be used for hiring and training of staff and establishing the field site. The 
following six months were to be used to screen 1,000 men from two trucking 
companies, in order to identify and em'ol 750 seronegative men, and the next 18 
months used to complete the follow-up period.
The first trucking company approached in Mombasa was the largest, Coast 
Hauliers. The management were orientated and gave permission for the men to come 
to Ganjoni clinic for follow-up. A general meeting of the men was held in the 
company yard and the programme was explained. The second largest company in 
Mombasa, Bayusuf Brothers, was contacted and the process repeated. Screening and
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counselling services were planned and organised in Ganjoni clinic. After a period of 
two weeks, no men had been screened. One reason for this was that our arrival in 
Mombasa had coincided vrith articles in the local newspapers specifically identifying 
truck drivers as the cause of much of the spread of the epidemic. It was necessary to 
re-think the screening and follow-up strategy, and it was decided to take the clinic to 
the trucking company depots.
Two other issues became appai'ent. Firstly, there were insufficient long­
distance drivers and their assistants to meet the sample size requirements, so a 
decision was taken to recruit all male employees. This Included ancillary staff, such 
as mechanics, fuel men, tyre boys, storemen, and administrative staff such as clerks 
and personnel workers. This meant that no pre-screening process was necessary, so 
barriers to access were reduced. It was also made clear that if men pai ticipated in the 
study, there would be an open door policy on primary health care and counselling.
Secondly, it was clear that there were insufficient men in only two companies.
The orientation and recruitment process was repeated in four other companies:
Interheight Panalpina, Transami, Siginon Freight and Anwarali Brothers. One other 
company, Transpares, was approached but the company management stated that they 
would require to have the results of FIIV screening of individual men made available 
to them, so their participation was not pursued. The selection of companies for 
participation was done on the basis of size, in the absence of any prior knowledge that 
any company would be more or less suitable than another. All companies were
located in the industrial area of the town, Eacfi participating taicking company was visited on 
an arranged morning each week, and the clinia finished when everyone
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who wanted to be seen for study or health care purposes had been attended to. The 
smallest company, Interfreight Panalpina, was visited on Wednesday afternoons, but 
so few men attended the clinic that it was stopped after one year. Access to health 
care and follow-up continued to be offered to men of all companies each weekday 
afternoon at Ganjoni clinic.
The mobile health team consisted of physician, nurses, health educator and 
counsellor, clerical assistant, and driver. Informal group discussions were held by the 
health educator at each company visit for men interested in joining the project or 
requesting information on health related issues. This was done in one of two ways. 
The most common was for him to place himself in a visible position in the yard, 
reading the newspaper. Men would then approach him and ask for verification and 
clarification of stories that they had heard about STDs and HIV. The second was for 
him to approach groups of men during their breaks and join in the conversation, which 
would invariably turn to requests for information on sexual safety matters.
In order to keep the clinic flowing, tliree separate areas were required:
• For examination and post-test counselling
• For HIV-1 screening and pre-test counselling
• For em'olment and follow-up interviews
As none of the companies would allocate more than two rooms, the project vehicle 
was used as an interview room for the duration of the project.
While we welcomed men who were HIV-1 seropositive at the clinic for care 
and follow-up, we did not actively tiy to trace them, as the goal was to gather a cohort 
of HIV-1 seronegative men. A database of the names, company, study numbers, and
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date of last HIV ELISA blood test of the men were stored. Each day, after entering 
the results of the blood tests in the lab data file, the author or Dr Rakwar entered the 
date that the next follow-up was due. Only the two project physicians had access to 
the computer files, where the serostatus of the men was entered, in order to maintain 
confidentiality. Each morning, before leaving for the trucking depot, a list o f men 
who were due for follow-up was printed out. A young man was employed to go 
round the depot and ask if the men on the list were in the depot on that day. If they 
were, he would ask them to come to the clinic, if not he would ask their friends to 
remind them to come next time.
As previously stated, it was necessary to adapt the recruitment design as the
situation on the ground became clearer. The numbers of men recruited in the first 10
months (1993) were as follows:
Mai'ch 99
April 131
May 57
June 47
July 74
August 61
September 43
October 27
November 41
December 19
This gave a total of 599 men after 10 months, over 150 less than the 6 month 
target. Measurement of the total number of men who may have been eligible for 
recruitment and follow-up was not attempted for the reasons outlined below. It was 
important that the project was seen by the men to be independent of the company 
management, in order to maintain the trust of the men that confidentiality was
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observed. There was a perception among men that, if the company knew that a man 
was HIV seropositive, he would be dismissed. This was not stated company policy, 
but it is now becoming increasingly common practice in Kenya for companies to send 
prospective employees for a medical examination, including a blood test. The HIV 
test result is conveyed directly to the employer. In the event of a positive HIV blood 
test the man is simply informed that he has not been successful and will not be 
employed. Formal contact with the management was kept to a minimum and 
employee information was not sought from the companies, in order to avoid the 
expectation that exchange of information would he reciprocated.
The companies all had up-country depots in Nairobi, or the west of Kenya. 
Men were moved between depots depending on the balance of the company work­
load. The types of contracts secured by companies could also cause fluctuations in the 
employment and deployment of men. An example of this was a large contract won by 
Bayusuf Brothers in 1993, to supply relief food to southern Somalia. Often at that 
time the depot would be almost empty, with the trucks all out and the mechanics 
doing running repairs between Mombasa and the Somali border, or full with the trucks 
being loaded, depending on the arrival of ships in the port.
The conditions of employment of truck drivers specifically dictate that they are 
highly mobile. Work assignments may take them from Mombasa to Sudan, Ethiopia, 
Rwanda or the east of Democratic Republic of Congo (Zaire) for well over a month at 
a time. This interfered with the regularity of availability for follow-up, and the 
accuracy of calculations of STD incidence. For example, if a man developed 
symptomatic urethritis while he was in Uganda or Rwanda, he would attend a
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practitioner for treatment at that location. If cure was achieved, he would not have 
had any investigations done at the research clinic and have may chosen not to report 
the episode at the research clinic.
Because of these factors, and the fact that there was no candidate vaccine to 
test in early 1994, the study moved into an open cohort design by necessity rather than 
by any process of active planning. Heyward and associates, in a paper examining the 
methods for the determination of HIV-1 incidence for the purposes of phase III 
vaccine efficacy trials, determined that the open cohort may be more suitable for the 
development of a well characterised cohort available to participate in HIV-1 
preventive vaccine efficacy trials [5]. For this reason, men were not designated as 
“lost to follow-up” from the cohort studies, and any time between follow-up visits 
included for the purposes of calculation of HIV-1 seroincidence. The primary 
outcome, HIV-1 acquisition, could still be measured with infrequent or intennittent 
follow-up, but collection of data on time varying correlates of HIV-1 infection, such 
as symptomatic STDs, would be less complete. The collection of data on 
symptomatic STDs was also incomplete due to the nature of the cohort, with men who 
were travelling seeking treatment at other clinics between follow-up visits.
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Section 2: Literature Review
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The HIV Pandemic
Since the first cases of a new clinical syndrome, which was named the 
acquired immunodeficiency syndrome (AIDS), were identified in the United States 
1981, the HIV epidemic has spread throughout the world, often at an alarming pace 
[6]. The epidemic was initially called the “gay plague” in the media, because the 
clinical syndrome was first recognised in homosexual men. The laboratories of Gallo 
in the USA, and Montagnier in France reported the isolation of a human T-cell 
leukemia virus in subjects with AIDS, and at high-risk of AIDS respectively, in the 
same edition of the journal Science in 1983 [7,8]. This became known as HTLV-III 
before the current nomenclature of human immunodeficiency virus type 1 (HIV-1) 
and type 2 (HIV-2) came into common use. HIV-1 has been the strain responsible for 
the global pandemic, and is the strain which has been discussed exclusively in this 
thesis. HIV-2 is primarily found in west Africa, although some HIV-2 infections have 
been found in Angola and Mozambique in the southern hemisphere [9,10].
There are thr ee main modes of HIV transmission. Sexual transmission is the 
most important, with over 80% of infections worldwide [11], and it is this mode of 
transmission which has been addressed in this thesis. Homosexual transmission was 
the predominant mode of transmission in the industrialised countries of Europe, North 
America and Australasia in the early phases of the epidemic, but there is evidence of 
rising trends in heterosexual transmission in industrialised countries [12].
Heterosexual transmission has been responsible for the rapid spread in developing 
countries in Africa and Asia, and the percentage of infected adults in the world who 
ar e women rose from 25% in 1990 to 45% by 1995 [13]. A mixed picture of the
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importance of homosexual, heterosexual and injecting drug use in the evolution of the 
epidemic has been seen in South America and the Caribbean, with heterosexual spread 
now becoming more important [14,15].
Perinatal transmission, from mother to child in utero, intra-partum and through 
breast-feeding, is the next most important mode of spread globally [16]. Parenteral 
transmission is the third most important, either through transfusion of blood or blood 
products, or injecting drug use [17,18]. A striking example of different modes of 
transmission leading to identifiably separate epidemics has been reported from 
Thailand [19,20]. However, although two different sub-types of HIV-1 were 
identified in adults presumed infected through heterosexual intercourse (sub-type E) 
and through injecting drug use (sub-type B) early in the epidemic, later studies have 
shown a considerable degree of cross-over of subtypes [21].
While the HIV-1 risk for recipients of blood products in many 
countries has been eliminated, blood transfusions still play a role in HIV-1 
transmission in Kenya, especially to the groups most likely to receive transfusions in 
malarious regions, women of reproductive age and children [22].
Quimi outlined four main phases of evolution of the HIV pandemic [23]:
• emergence
• dissemination
• escalation
• stabilisation.
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He also asserts that the long incubatioh period, of up to and beyond ten years 
between HIV infection and HIV disease, has helped the epidemic to spread throughout 
the world unchecked. A study from Zaire in west-central Africa by Nzilambi and 
colleagues [24], is of special importance in this regard. In 1985, investigators tested 
659 human serum samples collected in the remote Equateur province of Zaire in 1976, 
for antibody to HIV. Five (0.8 %) were found to be positive. Follow-up 
investigations in 1985 revealed that three of the five seropositive persons had died of 
illnesses suggestive of AIDS, and two remained healthy but seropositive. They
i:
conducted a repeat serosurvey in the same region in 1986, and showed a 
seroprevalence of 0.8% in 389 randomly selected residents. The investigators 
concluded that the long-term stability of HIV infection in residents of rural Zaire 
suggested that social change may have promoted the spread of AIDS in Africa, 
allowing the infection to emerge from remote mral areas, to be spread in urban 
centres.
The infection was disseminated to various parts of the world by tra vel, both 
internationally and through internal migration. Escalation occurred when the
epidemic was amplifred through high-risk populations, such as female sex workers, 
the male clients of sex workers, intravenous drug users and promiscuous homosexual 
men. The fourth stage, stabilisation, has occurred in Europe, North America, and 
Australia, and Quinn suggests that this may represent a degree of success in HIV 
prevention programmes, or equally that the epidemic is moving to an endemic phase. 
There is also evidence that the epidemic is stabilising, albeit at a much higher level, in 
parts of Africa, and this will be discussed in the appropriate section.
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The UNAIDS/WHO Working Group on Global HÏV/AIDS and STD estimated
that 30.6 million people were living with HIV/AIDS by November 1997, in their
update in the Weekly Epidemiological Record, published by the World Health
Organisation [11] Almost six million of these were estimated to have been newly
infected in 1997. The breakdown by geographic region is given in Table 1 below.
Table 1; Estimated number of adults and children living with HIV/AIDS as of 
November 1997, by region. [11]
Adults and children estimated to be living with HIV/AIDS as of November 1997
Industrialised Regions
North America 860,000
Western Europe 530,000
Australia & New Zealand 12,000
Regions with Mixed (Rich and Poor) Economy Countries
Eastern Europe & Central Asia 150,000
North Africa & Middle East 210,000
East Asia & Pacific 440,000
Caribbean 310,000
Developing Regions
Latin America 1.3 million
South & South-East Asia 6.0 million
Sub-Saharan Africa 20.8 million
Total 30.6 million
In addition, it was estimated that 11.7 million people had died of AIDS by the 
end o f 1997, 2.3 million of these deaths occurring in that year. Forty six percent of 
those who have died of AIDS were women, and 460,000 were children. A total of
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1,736,958 AIDS cases had been reported by all countries up to November 20, 1997. 
There is great variation by country in the proportion of AIDS cases which are 
reported, with the lowest proportion reported from the developing countries which are 
worst affected.
Over 90% of HIV infections have occurred in developing countries, with two 
thirds of the total in sub-Saliaran Africa, which has an estimated overall HIV 
seroprevalence of 7.4% in adults aged from 15 to 49 years.
The seroprevalence rates in the general population in Asia are lower but, 
because o f the large population size, there is a danger of explosive epidemics.
Warning of this was given in the documented HIV-1 seroprevalence of 47% and 
seroincidence of 16% per annum in sex workers in Bombay in the early 1990’s [25].
In addition, epidemics may vary widely in speed and intensity of progress, even 
within countries, as evidenced by the fact that the HIV-1 seroprevalence in sex 
workers in New Delhi remained stable at less than 1%, during the period of rapid rise 
in their peers in Bombay [26].
Although there have been some successes in the developed world, for example 
the decreased HIV-1 seroincidence among homosexual men as a result of safer sex 
practices [27], reduced acquisition of infection among injecting drug users because of 
altered needle sharing or cleaning practices [28], the failure of current approaches to 
control the epidemic in many high risk communities is obvious. Research 
demonstration projects have documented that HIV-1 acquisition can be slowed among 
female sex workers (FSW), an important core group in many developing countries 
[29,30]. However these programs have not been replicated on a large scale in most
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countries, and the number of infected individuals globally continues to climb rapidly. 
The explosive spread of HIV-1 in Thailand, despite the accepted intei*vention tools of 
behaviour modification, condom promotion, and sexually transmitted disease control, 
was a reminder of the limitations of existing control strategies in the initial phases of 
the epidemic [31]. It is true, however, that serial surveys of twenty one year old male 
army conscripts in Thailand, up to 1995, produced convincing evidence of decreased 
risk behaviour, leading to a decrease in HIV-1 infection in young men [32].
Because of the global nature o f the epidemic, outlined above, the United 
States National Institutes of Health sponsored nine international sites to prepare for 
vaccine and non-vaccine HIV-1 preventive interventions, four of which were in 
countries in sub-Saharan Africa: Malawi, Uganda, Rwanda (subsequently moved to 
Zambia), and Kenya.
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HIV-1 Epidemiology in Sub-Saharan Africa
As stated above, it has been estimated that by the end of 1997, 68% 
(20.8million) of people living with HIV/AIDS were in sub-Saharan Africa, with the 
vast majority of adult infections transmitted through heterosexual intercourse. The 
National AIDS and STD Control Programme (NASCOP) of the Ministry of Health of 
the Government of Kenya, estimate that 75% of all HIV-1 infections in Kenya are 
attributable to heterosexual vaginal transmission, 20% ar e attributable to vertical 
transmission from mother to child, and 5% are due to blood transfusion [22].
Injecting drug use and anal intercourse are uncommon and not thought to contribute 
significantly to the magnitude of the HIV-1 epidemic in sub-Saharan Africa.
UN AIDS has estimated that 90% of the thiee million infants born with HIV-1 
infection were in sub-Saharan Africa [33].
Within each country, and regions of each country, the epidemic has progressed 
with varying speed in different population groups. The reasons for the full extent of 
the diversity of transmission rates have not been fully elucidated. Work done in 
Malawi, and published in the Joui'nal of Infectious Diseases in June 1998, compared 
semen HIV-1 RNA concentrations of HIV-1 infected Malawian men with HIV-1 
infected men who had never had anti-retroviral therapy, from Switzerland and the 
USA [34]. HIV-1 RNA concentrations in semen were over tlnee times higher in 
Malawian men, in the absence of any urethritis and, while the reasons for these 
differences are not yet known, the investigators suggest that they may help explain the 
high rates of HIV-1 transmission in sub-Saharan Africa.
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While information on male groups is sparse, studies have recorded HIV-1 
seroprevalence among women attending antenatal clinics in eastern and southern 
Africa for more than ten years, with levels increasing in recent years to 30% or more 
in many urban centres [35-39]. Pregnant women are valuable as a sentinel group 
because they are sexually active, attend health facilities for reasons other than illness, 
and come from all social groups within society. They also give an indication of 
differences in background seroprevalence between different locations. However, a 
recent study from the Rakai area in Uganda has suggested that HIV-1 seroprevalence 
among pregnant women may underestimate true seroprevalence in similar birth and 
gender cohorts, due to an adverse effect of HIV-1 infection on fertility [40]. Another 
community study from Uganda has shown that prevalence has started to stabilise, and 
that an endemic phase of the HIV-1 epidemic may have begun in some areas [41]. 
Community HIV-1 seroprevalence in this advanced phase will be sustained by young 
people commencing sexual activity entering the susceptible population pool, and it is 
anticipated that peak HIV-1 incidence will be concentrated in the younger age groups 
[42]. In Malawi, pregnant women under 20 years of age were shown to have the 
highest annual HIV-1 seroincidence, at almost 6% per annum [43].
Antenatal surveillance data from municipal clinics in Nairobi, with lower 
socio-economic group catcliment areas, are presented below. These data have 
contributed to the National Sentinel Surveillance Survey data, and have also been 
published, in part, in the AIDS in Kenya 1998 edition [22]. Table 2 shows province 
of origin of the 6,828 women who were screened, by HIV-1 serostatus.
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Table 2: Province of origin and HIV-1 serostatus of 6,828 pregnant women screened 
in Nairobi, 1991-1997.
Total 
[n=6828] 
(Percentage o f  total)
HIV-1 Positive 
[n=1004] 
(Percentage from each 
Province)
Province o f  Origin
Coast 61 ( 0.9%) 5 ( 8.2%)
North eastern 137 ( 2.0%) 10 ( 7.3%)
Eastern 748 (11.0%) 68 ( 9.1%)
Central 1810 (26.5%) 162 ( 9.0%)
Nairobi 94 ( 1.4%) 9 ( 9.6%)
Rift valley 219 ( 3.2%) 34 (15.5%)
Western 1485 (21.7%) 207 (13.9%)
Nyanza 2274 (33.3%) 509 (22.4%)
One-third of women reported that their province of origin was Nyanza, in the 
extreme west of the country, and one quarter came from Western or Rift Valley 
provinces, two neighbouring provinces in western and central-west Kenya (Figure 1). 
The location of Mombasa, the study site, is indicated on that map. HIV-1 
seroprevalence was significantly higher in Nyanza than in the other provinces (22.4%, 
95% Cl 20.9-23.9), and women from Western and Rift Valley provinces were more 
likely to be HIV-1 infected (14.1%, 95% Cl 12.7-15.5) than women from Nairobi, 
Central, Eastern, North Eastern and Coast provinces (8.9%, 95% Cl 8.3-9.5), P <
0.001. Some issues related to these differences are discussed below.
It is noteworthy that less than 2% of women gave their province of origin as 
Nairobi. One reason for this is that while people may have lived in Nairobi for many 
years, they still perceive themselves as part of a family group which lives in the ethnic 
home province. Another observation, made by Ferguson in a fertility and family 
planning study in two rural areas in Western and Eastern Provinces [44], is that there
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are regional differences in male migration, with 59% of men from the mral Western 
Province study ai-ea living away from home compared with 21% from Eastern 
Province. The temporal pattern of migration also differed, with men from Western 
Province returning home only at Christmas and Easter, whereas men from Eastern 
Province often returned home on a monthly basis, because of easier access. The 
potential importance of this difference ;will be discussed in the body of the thesis.
It has been noted that fertility levels vary widely in different localities in 
Nairobi, localities with the highest fertility being those occupied largely by etlinic 
groups from western Kenya [45]. This was interpreted as suggesting that the cultural 
practices of the ethnic groups who migrate to Nairobi remain the same, perpetuating 
customs which led to the differential fertility rates. It may be that this also applies to 
sexual network patterns, contributing to differences in HIV-1 seroprevalence.
Hunter, Kapiga and colleagues have reported that lack of circumcision in the 
husband is associated with increased HIV-1 seroprevalence in pregnant women in 
Nairobi [3] and with increased seroincidence in pregnant women in Dar es Salaam 
[46]. The association in general between lack of male circumcision and risk for HIV- 
1 infection has also been reviewed in detail [47], and will be addressed in this thesis. 
The main etlmic group which does not practice male circumcision in Kenya comes 
from Nyanza Province [3].
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Gregson and colleagues have suggested methods of using age-specific HIV-1 
prevalence data to measure HIV-1 incidence in stable endemic conditions [42], They 
note that very young women who attend for antenatal care may be at higher risk of 
infection, as they are sexually active at a young age. On the other hand, caution 
should be exercised in interpreting falls in HIV-1 seroprevalence as falls in incidence, 
even in young people, as appaient falls in age-specific prevalence may at least in part 
be accounted for by mortality, migration, aging and higher absenteeism among HIV-1 
positive individuals [48].
HIV-1 seroprevalence was almost 15% in the “low-risk” group of pregnant 
women, included in the Nairobi surveillance data. Differences by province of origin 
were consistent with those found in unlinked, anonymous antenatal testing performed 
by the Kenyan National Sentinel Surveillance Survey up to 1997, extracts of which 
which are reported in table 3 below [22] :
Table 3: Percentage of pregnant women testing positive for HIV-1 in unlinked 
anonymous testing in Kenya. (AIDS in Kenya [22]; reproduced by permission of the 
author, Elizabeth Pisani)
Sentinel Site 1990 1993 1995 1997
Garissa (NE) 4.9 3.8 5.8 8.1
Mombasa (Cst) 10.2 16.5 15.8 17.4
Meru (E) 2.7 2.3 8.7 13.8
Nyeri (Cnt) 2.9 5.4 9.6 10.1
Nakuru (RV) 10.0 22.5 27.2 24.6
Busia (W) 17.1 22.2 22.0 28.1
Kisumu (Nyz) 19.2 19.6 253 34.9
North Eastern = N 
Western = W, Nya
3, Coast = Cst, 
nza = Nyz
Eastern = E, Central = Cnt, Ril\  valley = RV,
Past experience has shown that the peak age of HIV-1 prevalence (and 
incidence) in males is approximately 5 years older than in females in East Africa
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[49,42]. This is reflected in the age and gender pattern of AIDS cases reported to the 
kenyan National AIDS and STD Control Programme between 1986 and 1997, 
represented in figure 2, and consistent with mortality data from Uganda [49]:
Figure 2: Age and sex  distribution of reported  AIDS ca se s  in Kenya, 1986-1997
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(AIDS in Kenya [22]: reproduced by permission of the author, Elizabeth Pisani)
The Kenya Demographic and Health Survey (KHDS) of 1993 reported that 
men were older at first marriage with a median age difference between husband and 
wife of seven years [50]. The median age at first marriage of urban Kenyan women 
was 20.6 years. Under 5% of women of any age reported more than one sex partner in 
the previous six months. Forty five per-cent of men aged between 20 and 24 reported 
more than one sex partner in the previous six months, and 24% of men in that age 
group reported 3 or more sex paitners in the previous six months. It follows that, if a 
twenty yeai* old woman now manies a twenty seven year old man, he has been 
tlu'ough his period of highest risk sexual activity in an extremely high risk 
environment, and she may be in grave danger because of his past activity. A 
reflection of this is that, of 1059 pregnant women in Nairobi, screened between 1991
[jjMale 
m Female
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and 1997, who reported one lifetime sexual partner and who had no perceived risk of 
AIDS, 80 (7.6%) were infected with HIV-1 (unpublished data).
AIDS is already the leading cause of adult death in some urban and rural areas 
of sub-Saharan Africa [49, 51], and models of the course of the epidemic predict that 
this will soon be the case for many other pails of this region [52]. The importance of 
co-factors, such as STDs and uncircumcised status in men, in the rapid spread of the 
HIV-1 epidemic among heterosexual STD high-frequency transmitter core groups (see 
below) in east and central Africa is well documented [47,54]. Interventions to 
decrease the prevalence and incidence of STDs in the general community have been
targeted at core groups, such as female sex workers (FSWs) and their clients [54]. Tiuck 
drivers have been identified as a male occupational group at high risk of STD and HIV-1 
acquisition, who may play an important role ill dissemination of these infections because of 
their geographic mobility [1].
The need for more effective interventions to control the current HIV-1 
epidemic is clear, and a vaccine would hold the most promise for prevention of new 
infections. The ideal vaccine would be cheap, safe, highly efficacious when given as 
a single dose, and associated with lifelong sterilising immunity to all strain types of 
HIV. While the quest for a vaccine with these properties continues in many centres, 
preparation for safety and efficacy trials in human populations has been conducted 
simultaneously in many countries worldwide.
In the absence of a vaccine of high preventive efficacy, there is a clear need to 
identify other practical interventions which will reduce HIV-1 transmission.
Behaviour change programmes, incoiporating health education, risk reduction
counselling, STD care and condom promotion, have been successful in decreasing 
HIV-1 incidence in female sex workers in Africa and homosexual men in North 
America [27,30]. However, there are few examples of prospective data on the ability 
of educational interventions to effect changes in sexual behaviour and incidence of 
HIV-1 or STDs in heterosexual male cohorts.
This cohort is one of only four non-clinic based studies in Africa (3 
prospective) which have published data examining male HIV-1 and STD acquisition, 
and that of male circumcision as an HIV-1 public health intervention strategy [55-57].
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STD Epidemiology
STDs are ranked among the top five categories for which adults attend health 
care clinics in developing countries [58]. They are an important cause of morbidity, 
including neonatal infections and stillbirths, and infertility in sub-Saharan Africa [59], 
and they contribute to the scale of the cunent HIV-1 epidemic in this region [54].
Apart from HIV-1, the STDs which were the focus of this thesis are the five 
most common curable STDs: gononlioea (Ngonorrhoeae), chlamydia (C 
trachomatis), trichomonas {T vaginalis), chancroid {H ducreyi) and syphilis {T 
pallidum). The world Health Organisation estimated in 1995 that there were 333 million new 
cases o f curable STDs worldwide; 12 million syphilis, 62 million gonorrhoea, 89 million 
chlamydia, and 170 million trichomoniasis [59i]. They also estimate that sub-Saharan Africa 
has the highest incidence, with 11-35% of 15 tp 49 year-olds becoming infected with a 
curable STD over the course of a year. =
Transmission co-efficients for sexually transmitted diseases can be defined as 
the fraction or percentage of sexual contacts which result in transmission, when one 
partner is infected. An equation which has been used to describe the basic 
reproductive rate (R J of an STD is [60] :
Ro = PcD
where (3 is the transmission co-efficient, c is the effective rate of partner change and D 
is the duration of infectivity.
The transmission co-efficients of the STDs between partners, as given in the 
appropriate chapters of the standard text. Sexually Transmitted Diseases, edited by 
Professor King Holmes and others, are outlined below [61]:
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T pallidum 30% from patients in primaiy or secondary phase
H  ducreyi 59% from men with ulcers to female sex partners
T vasinalis 33% female to male, 85% male to female
C trachomatis 45% male to female
N  sonorrhoeae 20% per sexual contact female to male
50%~90% per sexual contact male to female.
Clearly such estimates are approximate, as tracing all contacts and persuading 
them to attend for investigation is at the very least difficult, and there is a potential for 
bias in that people with low-grade symptoms of infection may be more likely to attend 
as a result of tracing.
Thomas and Tucker reviewed the development and use of the concept of a 
sexually transmitted disease core group, which is central to the calculation of c, the 
effective rate of partner change [62]. They noted that the term has been used to refer 
to people who are infected a large proportion of the time, infect more than one person, 
are repeatedly infected, are sex workers and their clients, or to geographic areas with 
large numbers of cases. They call for more research interventions targeting strategic 
groups to evaluate their effectiveness. A percentage of trucking workers fit into more 
than one category outlined, and they have been the subject of sexual behaviour and 
STD research and intervention on three continents [1,63,64]. They can also be viewed 
as a “bridging population” for STD spread between members o f high-prevalence and 
low-prevalence sub-populations. Wasserheit and Aral believe that these bridging 
populations may be the most important agents of STD spread thi’oughout society, as 
they have concuixent sexual relationships with high and low risk groups [65]. FSWs
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living in Kenya, who are often the “high-risk” partners of these men, have 
seroprevalences of HIV-1 infection as high as 80% in Nairobi and 55% in Mombasa 
[66,67], The seroprevalences of the “low-risk” partners was addressed in the 
preceding section of the introduction. Stigum and colleagues have pointed out the 
importance of people who move between “core” and “non-core” behaviour in HIV-1 
transmission [68]. While their work refers to the Norwegian situation, the same 
principle applies to men in Kenya who act as part of a core group when they live away 
from home, and as non-core when they live at home.
The durations of infectivity (D), quoted in the respective Natural History 
sections of the King Holmes standard text, are given below:
T pallidum during primary or secondary phases - can be years.
H  ducreyi until ulcers or discharging buboes heal. One or two weeks with
antibiotics, usually approximately 10 weeks without antibiotics 
T vasinalis Can be several years in women.
C trachomatis Unknown. Thought to be many years
N  sonorrhoeae Resolution occurs within six months in over 95% of untreated 
men
Ulcerative STDs, such as chancroid, have been implicated most often as 
facilitating HIV-1 transmission [69], but prospective studies from Kenya [70] and 
Zaire [71] have found that the presence of non-ulcerative sexually transmitted diseases 
also increase the risk of acquiring HIV-1 infection. Retrospective studies from Kenya 
[1], Côte d'Ivoire [72] and India [73] have also reported associations between history 
of urethral discharge and HIV-1 infection. However, little is known about the
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epidemiology of urethml infection among men in Africa, and about asymptomatic 
infection in particular.
Asymptomatic urethral infections may be more common than is generally 
supposed. Cross-sectional studies in the United States have revealed prevalences of 
up to 5% for Neisseria gonorrhoeae and 11% for Chlamydia trachomatis infections 
among asymptomatic young men who were at high-risk for STDs [74]. A study 
involving a general population of 6,000 men in rural Tanzania reported a combined 
prevalence of gonococcal and chlamydial infection of almost 3%, 85% of whom were 
asymptomatic [75]. Studies in the United States have shown that Trichomonas 
vaginalis can cause symptoms of urethritis [76], and that it can be carried 
asymptomatically in the male uretlira for at least four months [77]. It is unclear 
whether pathogens causing asymptomatic urethial infection are as efficiently 
transmitted as those associated with symptomatic infection, but it is likely that they do 
play a role in transmission, and must be identified and treated if the chain of 
transmission is to be successfully interrupted. Cohen and colleagues, working in 
Malawi, have shown that appropriate treatment of uretlual infections decreased HIV-1 
viral shedding in semen, potentially decreasing the transmission co-efficient for HIV- 
1 [78].
Active case finding is required to identify asymptomatic infection. In most 
African countries, however, because of cost and lack of infrastructure, it is usually not 
possible to perform laboratory diagnostic tests on even symptomatic individuals. Risk 
assessment strategies and the use of simple, inexpensive screening tests have therefore 
been advocated to identify sexually transmitted infections in such populations [79]. In
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this regard, several North American investigators have evaluated the urine leucocyte 
esterase dipstick (LED) test, which identifies pyuria, and it has shown promise as a 
screening tool to identify N. gonorrhoeae and C. trachomatis infections among 
asymptomatic men [80-82]. It has also been favourably evaluated in two studies from 
Africa in screening for uretlu'al infection among primarily symptomatic men attending 
health facilities [883,84].
The prevalence of the three most important m etluul pathogens in a workplace 
population of both symptomatic and asymptomatic East African truck drivers and 
ancillary workers has been measured in this thesis. Various potential strategies for the 
screening and management of urethral infection, including use of the urine LED test, 
have been evaluated and we have attempted to identify demographic and behavioural 
risk factors which could provide guidance in the development of risk scores for 
screening purposes.
With the recent finding in a randomised, controlled community trial in 
Tanzania that HIV-1 transmission can be significantly reduced by an effective STD 
treatment programme [85], identifying and treating urethral infections in Africa 
becomes an even higher public health priority.
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HIV-1 and STD epidemiology
That transmission of HIV-1 is enhanced in the presence of many classical 
STDs (epidemiological synergy) is now well accepted [53,86-92]. As male 
acquisition of HIV-1 and STDs is the main focus of this thesis, emphasis will be 
placed on aspects of that interaction.
Mathematical modelling work done in Thailand on the probability of female- 
to-male transmission of HIV-1 infection per sexual contact [86], found that overall 
probability of of HIV-1 male acquisition was up to 5.6% per sex worker contact in the 
presence of STDs, and 1.2% with no STDs. A history of STDs increased this 
probability by a factor of between 3.3 and 5.1, and the degree of effect varied with 
different STDs. These estimates of probability of transmission of HIV-1 per sex act
(p) are higher than those seen in Western countries [93], but consistent with high rates of 
HIV-1 acquisition in men and women with gerfital ulcer disease in Nairobi [87].
The investigators concluded that the high prevalence of STDs in the sex worker 
population and the frequency of of sex worker contact by the military recruits may 
have contributed to to the rapid spread of HIV-1 infection in this population. This is 
given credance by the fact that studies in discordant couples in Thailand with a low 
prevalence of STDs found transmission coefficients similar to those in the West [94].
Historical data was used by Job Bwayo and colleagues on long-distance truck 
drivers, screened and surveyed at the Athi River weigh bridge station, 25 km east of 
Nairobi [1]. They found that a history of genital ulcer or history of urethritis in the 
past 5 years were statistically significantly associated with HIV-1 infection on 
multivariate analysis.
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Increased numbers of CD4 lymphocytes, which are target cells o f the HIV-1 
virus, are present in increased numbers in the endocervical canal of women with 
nonulcerative STDs [95]. Work done by Moss in Nairobi showed that HIV-1 DNA 
detection on urethral swabs could be reduced by appropriate treatment o f gononlioea 
and resolution of urethritis [92], and research by Cohen in Malawi showed that 
treatment of gonorrhoea also decreased quantitative shedding of HIV-1 in semen [78]. 
Lillienfreld outlined the discriminators used in making a causal inference between risk 
factors and disease or infection [96]:
• Strength of association
As we have seen, odds ratios of over 5 have been observed for history of STDs and 
identification of HIV-1 infection [86,91].
• Consistency of the observed association
The relationship between STDs and HIV-1 has been reported from a wide range of 
populations in different continents[ 10,27,32,37].
• Specificity of the association
Specificity has become less important as a criterion for causality, as the recognition of 
multifactorial aetiologies leading to disease has gained ground. An example of this is 
ischaemic heart disease, in which smoking and high cholesterol levels are exposures 
which are both accepted as causal. In this thesis, evidence will be examined as to why 
STDs, lack of male circumcision and occupational travel should all be viewed as 
having a causal association for HIV-1 infection.
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• Temporal sequence of events
This was well demonstrated by Cameron and colleagues in the Special Treatment 
Clinic in Nairobi, when men presented with genital ulcer disease and urethritis [91]. 
The initial HIV-1 seroprevalence was 12%, and 8.2% of seronegative men who 
returned for follow-up seroconveited to HIV-1 in the following 12 weeks.
• Dose-response relationship
It is often difficult to identify a gradient of exposure and incidence o f infection or 
disease and sometimes proxy indicators of exposure must he used. In the study by 
Cameron, referenced above, it was noted that newly acquired infection was 
independently associated with frequent sex worker contact (risk ratio 3.2), which may 
be considered as a proxy indicator of increased exposure to STDs, given the high 
prevalence of STDs in sex workers in Kenya [54,66].
• Biological plausibility of the observed association
Association of an infection which is transmitted by sexual contact (HIV-1) with 
diseases which either disrupt the integrity of the mucosal barrier or increase the 
shedding of the infectious particles at the site of infection is entirely plausible.
• Experimental evidence
Double-blind, randomised, controlled clinical trials are the gold standards of 
intervention research. However, there are very clear ethical problems in the design of 
any experimental study which involves exposure to an infection with such devastating 
effects as HIV-1. A community randomised and controlled research study, with 
improved STD management as the intervention, was carried out in Mwanza,
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Tanzania [85]. That study was carefully constructed to conform to ethical criteria, and 
reported a 42% decrease in new HIV-1 acquisition in the intervention communities.
As stated above, WHO estimate that sub-Sahaian Africa is the region most 
seriously affected by the epidemics of HIV-1, and other STDs. The literature on the 
relationship between HIV-1 and STD transmission, and the other potential correlates 
of sexually transmitted infections, male circumcision status and migration, aie 
discussed below.
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HIV-1 and Circumcision Status
There has been considerable debate over the role of uncircumcised status in the 
male in HIV-1 transmission over the past ten years. A Medline database search was 
conducted for entries from October 1993 to February 1998, to identify studies 
investigating the relationship between HIV-1 transmission and lack of male 
circumcision. The preceding period was covered by a review of this subject by 
Stephen Moses, referenced above. That review identified 30 epidemiological (26 
cross-sectional, two prospective and 2 ecological) studies, 15 of which were published 
in peer-review journals and 15 as conference abstracts. Eighteen of the 26 cross- 
sectional studies from 6 countries (Cote d’Ivoire, Kenya, Rwanda, Uganda, United 
States and Zambia) found a significant association between HIV-1 infection and lack 
of circumcision. Trends towards an association were found in four other countries 
(The Gambia, Mexico, Tanzania and the United States). The two prospective studies 
(from Kenya) and the two ecological studies from Africa all showed positive 
associations between the presence of a foreskin and HIV-1 acquisition. Measures of 
increased risk (odds ratios or relative risks) of between 1.5 and 8.4 were recorded in 
studies which showed a significant positive association. Many of these studies are 
referenced elsewhere in the thesis, but they are not referenced individually in this 
section. There is, however, one study which merits special mention, as it was caiTied 
out in the Dept of Medical Microbiology of the University of Nairobi and is still 
widely quoted, almost 10 year's after it was first published. Cameron and colleagues 
followed 293 male STD patients prospectively, and found that lack of circumcision 
was associated with a rate ratio of 8.1 (95% Cl, 3.4-19.7) for HIV-1 acquisition [91].
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Since that review, which was published in 1994, both Nasio and Tyndall have 
confirmed associations in Nairobi [97,98]. Nasio found an odds ratio of 4.67 for HIV- 
1 infection and uncircumcised status at enrollment of patients who presented with an 
STD at the Special Treatment Clinic (STC), and Tyndall found an odds ratio of 4.8 
(95% Cl, 3.3-7.2) in men who presented with genital ulcer disease, after adjusting for 
sexual exposure variables in a multivariate logistic regression model. Another cross- 
sectional study was carried out in Kigali, among married men who volunteered for 
counselling and HIV testing [99]. Uncircumcised men in that study had a relatively 
low-risk profile in that they reported fewer lifetime sex partners and sex worker 
contacts than circumcised men, and were more likely to live in rural areas where HIV- 
1 seroprevalence is lower. In spite of this, uncircumcised men were more likely to be 
infected with HIV-1 (29% vs. 21%, p=0.02). After adjusting for sexual behaviour 
variables, lack of circumcision remained significant (OR 1.69, 95% confidence 
interval 1.16-2.47). Urassa and colleagues published results of five population-based 
studies in north-western Tanzania [56]. On univariate analysis, circumcision status 
was umelated to HIV-1 infection in most of those five studies. However, after 
adjusting for confounding variables, HIV-1 seroprevalence was found to be less in 
circumcised men (OR 0,62; 95% Cl 0.48-0.81). The effect was strongest in urban 
areas (OR 0.46; 95% Cl, 0,32-0.68), and in roadside settlements (OR 0.65; 95% Cl,
0.42-1.01). The introduction of male circumcision as a mass HIV-1 prevention 
strategy has been under serious discussion since 1993 [100].
Causal inferences on lack of circumcision status and HIV-1 acquisition are discussed 
below:
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• Strength of association
The prospective study of Cameron and colleagues revealed a rate ratio over 8 [91], 
and another study by Tyndall, on 413 genital ulcer patients [98], published in 1996, 
found an odds ratio of 4.8.
• Consistency of the obseiwed association
Twenty two of the 30 studies reviewed by Moses [47], and all five of the referenced 
studies since, have shown a significant association between presence of the foreskin 
and HIV-1 infection.
• Specificity of the association
As uncircumcised men are also more susceptible to other STDs, especially genital 
ulcer disease, the specificity of the association is not certain [91]. This ;will be 
discussed flirther in the body of the thesis.
• Temporal sequence of events
In the published prospective study, the exposure clearly preceded infection. However, 
as circumcision is generally carried out either in infancy or at puberty, it could usually 
be shown to fulfill the temporal criterion.
• Dose-response relationship
Usually circumcision either has, or has not, been carried out and so the concept of a 
biological gradient does not apply. Bongaarts and colleagues did, however, apply this 
criterion to percentage of the population circumcised in their ecological study [101], 
and they found a strong inverse correlation (r=0.9, p<0.001) with seroprevalence of 
HIV-1.
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• Biological plausibility of the observed association
That an increased surface area of non-keratinised mucosa exposed to trauma during 
sexual intercourse may lead to an increase in the incidence of sexually transmitted 
diseases is clearly plausible. It is also possible that sub-clinical balanitis is a frequent 
occurrence in uncircumcised men, especially if levels of hygiene are not optimal [47]. 
These areas of minor inflammation could act like small ulcers, by disrupting the 
integrity of the mucosa. In addition, there may be recruitment of target lymphocytes 
to the inflamed area. It has been demonstrated that Langerhans cells, which are 
plentiful in the foreskin of male macaque monkeys, are highly susceptible to Simian 
Immunodeficiency Virus [102]. If this is also true for humans and HIV-1 infection, it 
may be that the foreskin is more vulnerable than the other tissues in the male genital 
tract.
• Experimental evidence
Experimental evidence, i.e. deliberately attempting to infect circumcised or 
uncircumcised humans, is not available for clear ethical reasons. However, the 
research in macaques referenced above is interesting in this regard.
In the absence of an authoritative randomised controlled trial, there continues 
to be debate on the potential benefits of the introduction of male circumcision as a 
population HIV-1 prevention strategy. Professor King Holmes suggested that we use 
this cohort to perform a randomised controlled trial to examine the relationship 
between HIV-1 and male circumcision status, but the available sample size was 
inadequate for this purpose.
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HIV-1 and Migration
There is now a large body of literature on the relationship between migration 
and HIV-1 infection, and throughout the ages any mass movement of men without 
their wives or girlfriends, whether for reason of war or economic necessity, has led to 
increased transmission of sexually transmitted diseases [103-114]. It is sub-Sahai-an 
Africa’s great misfortune that this turbulent period of development, urbanisation and 
wars has co-incided with this epidemic of a new sexually transmitted disease, which is 
enhanced by other STDs.
Causal inference criteria:
• Strength of association
A prospective cohort study in a rural Ugandan area found that seroincidence of HIV-1 
in people who had moved into the area in the past five years was more than double 
that of people who had been living in the area for more than ten years [103]. The 
investigators concluded that this was likely to be a result or more risky behaviour, and 
less stable sexual relationships, among those who were more mobile.
• Consistency of the observed association
Travel outside of the region or country of origin was one of the original recognised 
risk factors, and the reason why Dr Bwayo started the long-distance truck drivers 
study in Athi River in June 1989. Examples of HIV-1 transmission studies in five 
continents are included in the references [1,63,64,110,111].
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• Specificity of the association
As in all three of the factors (STDs, circumcision and migration) subjected to causal 
inference examination here, specificity is the most difficult of the criteria to speak 
clearly on, as there are so many societal, cultural, economic, physical and 
psychological factors which make people vulnerable to HIV-1 infection.
• Temporal sequence of events
The prospective study by Nunn and colleagues fiom Uganda referenced above clearly 
showed that the relationship satisfied this criteria, in that the study subjects were not 
infected before they moved fiom home.
• Dose-response relationship
It is still difficult for us to quantify the migration and HIV-1 association in a dose- 
response way, but Nunn and colleagues did find a gradient in HIV-1 seroprevelance 
with increased distance of migration in Uganda [103]. Anderson, in a paper on aspects 
of sexual behaviour and the potential demographic impact of AIDS in developing 
countries, called for more quantitative analysis of patterns of sexual mixing in 
communities [114]. The experience from Nakuru, in the Rift Valley (Figure 1), is 
possibly instructive in this respect. Sentinel surveillance in pregnant women in 1990 
revealed an HIV-1 seroprevalence of 10.0%, which had increased to 27.2% in 1995 
(Table 3). Compare this with Mombasa, a port city also on the trans-Africa highway, 
for which the seroprevalences in 1990 and 1995 were 10.2% and 15.8%, respectively. 
Nakuru is the capital of Rift Valley Province, which has been the site of 
internationally publicised “tribal clashes” thi’oughout in early 1990’s. These violent
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clashes were about land ownership and resulted in displacement of many people from 
their rural homes, forcing them to re-locate in urban Nakuru.
• Biological plausibility of the observed association
It is entirely plausible that disruption of family life, with separation of husband and 
wife, and removal of cultural safeguards leads to increased sexual risk behaviour and 
HIV-1 transmission.
• Experimental evidence
Ethical considerations preclude experimentation in this subject.
The findings of Nzilambi and colleagues in Zaire are of great interest in the 
relationship between HIV-1 transmission and migration [24]. They found that HIV-1 
remained endemic at a low level (<1%) over a ten year period, between 1976 and 
1986, in a stable rural population and concluded that social disruption and mobility 
led to the explosive epidemics seen in urban centres.
The existing literature gives sufficient a priori evidence that different types of 
sexual risk behavioui's, other STDs, circumcision status and migration patterns would 
potentially act as confounders in any vaccine or non-vaccine HIV-1 preventive 
intervention. The quantification of these variables, and their interaction with HIV-1 
acquisition, was deemed by the US National Institutes of Health to be important in the 
preparations for such research interventions.
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Section 3: Aims, Objectives and Project Timetable
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Aims
1. To characterise a heterosexual HIV-1 seronegative male cohort, at high risk of 
HIV-1 infection, for the purposes of inclusion in HIV-1 preventive vaccine trials.
2. To measure HIV-1 incidence and assess the following potential correlates of HIV- 
1 acquisition: other STDs, sexual risk behaviour, male circumcision status and 
occupational travel.
3. To determine the prevalence of symptomatic and asymptomatic curable urethral 
infections in male trucking workers and examine strategies for control.
4. To document the potential acceptability of an HIV preventive vaccine trial in the 
cohort of male trucking company workers.
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Objectives
1. Determine the HIV-1 seroprevalence in men screened for antibodies to HIV in 
trucking companies in Mombasa (Study 1).
2. Estimate the prevalence of symptomatic STDs at first presentation in the HIV-1 
seronegative male cohort (Study 2).
3. Calculate HIV-1 seroincidence and examine the effects of potential correlates of 
HIV acquisition in the male trucking company worker cohort (Study 3).
4. Monitor sexual risk behaviour over time in the male cohort of trucking company 
workers (Study 4).
5. Monitor STD incidence over time in the male cohort of trucking company workers 
(Study 5).
6. Measure the prevalence of symptomatic and asymptomatic urethral infection in 
the male cohort of trucking company workers (Study 6).
7. Survey male trucking workers for potential acceptance of the probable conditions 
of an HIV-1 preventive vaccine trial (Study 7)
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Table 4: Project Timetable and Thesis Study Guide (Also on inside cover)
October, 1992
United States National Institutes o f  Health approve research project 
“High-risk cohorts in Kenya: Prostitutes and Truckdrivers” as part o f  
the Preparation for the AIDS Vaccine Evaluation (PAVE) initiative
December 9, 1992
Author recruited to be Project Field Director by University o f  
Washington. Discussions in Seattle regarding project planning
January 25. 1993
Investigators gathered in Nairobi to begin 
prepaiations for implementation
February 7. 1993
Investigators travel to Mombasa to begin
Laboratory and clinic and trucking company preparations
February 15. 1993
Screening centre opened at Ganjoni Clinic
March 1-4. 1993
Mobile clinic started at Coast Hauliers (First men screened),
Bayusuf Brothers, Interfreight, and Transami.
(Siginon Freight added 31/3/93 and Anwarali Brothers added 14/7/93)
Studies 1 and 2: .March 8. 1993 -  January 31. 1996 Prevalence 
Enrollment and HIV-l prevalence data on 1367 men screened. STD 
prevalence data on 955 seronegative men.
1136 HlV-1 seronegative, 955 (84%) enrolled 
231 HlV-1 seropositive, 118 (51%) enrolled
Study 3: March 15. 1993 -  January 31 1996 Incidence
Routine follow-up and interim STD evaluation data collected for  
HIV-1 seroincidence and correlates o f  HIV-1 acquisition study 
955 HlV-1 seronegative men enrolled.
716 HlV-1 seronegative men (75%) contributed incidence data.
990 person years o f follow-up
Studies 4 and 5: March 15. 1993 -  October 14. 1994 Incidence  
Routine follow-up and interim STD evaluation data collected for  
time-trends analysis o f sexual behaviour and symptomatic STD 
incidence
1195 men screened, 206 (17%) seropositive.
836 (85%) o f 989 seronegative men enrolled.
556 men HlV-1 seronegative men contributed incidence data,
72 % o f  771 men eligible for routine follow-up  
(enrolled for 3 months or more by October 14, 1994)
494 person years o f follow-up
Study 6: October 17. 1 9 9 4 - July 28. 1995 Cross-sectional
Prevalence o f symptomatic and asymptomatic urethral infection
504 men; 429 HIV-1 seronegative, 75 (15%) HlV-1 seropositive. 
4(1% ) men refused urethral swabs
Study 7: September 8 1993 -  May 20. 1994
Vaccine acceptability survey
201 H IV -1 seronegative men surveyed
Cross-sectional
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Section 4: Methods
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Methods 
Enrolment and Routine Follow-up (Studies 1-5)
All of the health educators, nurses, and physicians received training in an 
HIV/STD counselling course by specialists from the University of Nairobi 
Department of Community Health, encompassing pre- and post-test HIV counselling, 
condom negotiation, demonstration, and promotion, and HIV/STD risk reduction.
The course was spread over a period of three months, with course work interspersed 
with in-service training provided by a professional counsellor employed by the 
project. Risk reduction health education materials, produced by the Kenyan Ministry 
of Health and local non-governmental organisations, were distributed. These 
materials contained information on HIV-1 and STD transmission, actively promoted 
100% condom use and sought to educate the men on the dangers of unprotected sex 
(without a condom) with a partner other than a spouse (extramarital sex). A supply of 
free condoms was offered to each man, after demonstrations of condom use, using 
penile models. A large box of condoms was placed in the waiting area at each 
company visit. Men were encouraged to come and take as many as they wanted, 
whether they wished to attend the clinic that day or not. Condom use with the spouse 
was not actively advocated for HIV-1 seronegative men, as it was considered 
practically unattainable and a distraction from the concept that they were in control of 
their own risk. Also, it was considered that the wife was the lowest risk sex partner, 
albeit not zero risk, and results are presented which are supportive of this assumption. 
The materials also advocated a reduction in the number of sexual partners, and sought 
to heighten the perception of personal risk.
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Verbal informed consent was obtained after individual pre-test counselling. 
Pre-test counselling contained all of the elements outlined in the consent form 
approved by the University of Washington Human Subjects Review Committee in 
August 1992 (Appendix 3). This document was not read verbatim, but rather 
explained section by section, in Kiswahili. Dr Rakwar did this, or the project 
counsellor, if the author was doing the clinic. If the project counsellor was doing the 
pre-test or post-test counselling, the author sat next to him, in order to answer any 
technical questions during the process of counselling and obtaining consent. After 
verbal consent was obtained, a 10 ml blood sample was then drawn for HIV and 
syphilis serology. Each individual was given a return appointment for the next week, 
at which time the physician provided results and post-test counselling. Post-test 
counselling after a negative HIV screening result had been conveyed consisted of the 
following elements:
• Advice on risk reduction, including the decreasing the number of sexual partners, 
condom promotion, and avoidance of other STDs.
• A discussion on the individual HIV/STD risk profile of the man and how he 
thought he might reduce that risk.
Post-test counselling after a confirmed positive HIV test included:
• The meaning of the positive test, and the state of current knowledge about what 
that meant for the way of life of the individual and his family.
• Information on the risk to others which his positive HIV serostatus carried, and 
detailed information on the activities which both could transmit the virus and 
those which would be unlikely to.
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• 100% Condom use was emphasised, especially with spouse.
• Men were informed that, while no cure for HIV disease currently existed, it was 
important to live positively, avoiding STDs by reducing the number of sexual 
partners and 100% condom use. In this way, if a cure became available, they may 
still be strong enough to benefit from it.
An enrolment questioimaire regarding demographic and occupational 
variables, medical history, and sexual behaviour was completed and a physical 
examination, including genital examination, was performed. The enrolment and 
examination questionnaires are included as appendices 4 and 5, respectively. The 
coding sheets are included in the appendices.
Subjects were informed that they would have open access to free primary 
health care, including sexually transmitted disease diagnosis and management, at each 
mobile team visit, regardless of serostatus. All men were appropriately treated and 
counselled according to Kenya national STD/HIV management guidelines (Figure 3). 
The guidelines are in the form of a flowchart and employ clinical algorithms, so that 
men could be treated immediately, without waiting for laboratory results. This was 
important in this highly mobile population, for individual compliance and for 
secondary prevention of STD transmission. The algorithmic approach is now 
favoured for STD control in developing countries and has been shown to assist in 
decreasing STD prevalence [115]. These procedures were canied out in all 1367 
study subjects who have data included in study 1.
Men returned for follow-up at three monthly intervals, or as close as their 
work schedule allowed. At each follow-up visit, a questionnaire on interim sexual
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behaviour and medical history was completed, physical examination performed, and a 
10 ml blood sample drawn for HIV serology. Further risk-reduction coimselling and 
condom promotion was carried out at these follow-up visits, and one week later when 
they returned for results. The follow-up questionnaires (appendix 6), physical 
examination and counselling procedures were canied out on all subjects who 
contributed to the incidence data included in studies 3, 5 and 6.
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Interim Follow-up and STD evaluation (Studies 3 - 5 )
Men with symptoms or signs of STDs, at either scheduled or interim visits, 
underwent additional evaluation. A follow-up questionnaire was completed (appendix 
6) and physical examination performed, as for routine follow-up. Uretlii’al discharges 
were investigated by gram stain and culture for Neisseria gonorrhoeae. Urethritis was 
defined as positive N  gonorrhoeae culture or urethml inflammation on gram stain 
(see below) and confirmed urethial discharge. Genital ulcers were evaluated for the 
presence of Haemophilus ducreyi by culture. Syphilis serologic testing was repeated 
on all subjects after 12 months of follow-up.
This full STD evaluation was canied out in all HIV-1 seronegative male study 
subjects, either at screening, for the prevalence studies, and follow-up for the 
incidence studies. The formal em*olment of seropositive men was not anticipated, and 
only started two months after the project had started. The HIV-1 seropositive men 
received full, free and equal treatment for STDs (Figure 3) and were encouraged to 
attend the clinic with symptomatic STDs and other illnesses. They were not, 
however, traced for follow-up in the same way as seronegative men or had STD 
specimens fully evaluated. For this reason, only the STD data for the seronegative 
men ar'e included in Studies 2, 3, and 5.
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Urethral infection Study Enrolment (Study 6)
All men, HIV-1 seropositive and HIV-1 seronegative, were invited to 
participate in the cross-sectional urethral infection study (Study 6), when they 
attended the clinic for follow-up or illness, between October 1994 and August 1995.
A medical and sexual history (Appendix 7) was taken and a physical examination was 
performed (Appendix 5) on all men. As can be seen from the questionnaire, the study 
was initially planned as a prospective study, but it became obvious that, while 
asymptomatic men would submit to one uretlmal swab, they would refuse more. Plans 
to repeat evaluation after treatment of any infection found were also abandoned for 
that reason. Only 1 % of the men who attended the clinics declined participation in the 
study, by reftising to have a urethial swab taken. A total of 504 men were recruited 
consecutively in this manner. All men were appropriately treated and counselled on 
the basis of laboratory findings, using the antibiotics outlined in the Kenya national 
STD/HIV management guidelines (figure 3), with the addition of metronidazole 2gm 
as a single oral dose for T vaginalis infection.
Figure 3: Kenyan Ministry of Health STD Guidelines
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Vaccine Acceptability Survey Enrolment (Study 7)
The vaccine acceptability questionnaire (Appendix 8) was administered to a 
convenience sample of 201 seronegative men during a follow-up visit for the cohort 
study between September 1993 and May 1994.
A convenience sample selection process was chosen for logistic reasons. In effect, 
5 or 6 men attending the clinic on any given day were asked to participate, as they left 
the clinic after a follow-up visit. The vaccine acceptability questionnaire took longer 
to complete than the follow-up visits. The vaccine acceptability interviewer waited 
until a subject left the examination area and requested their participation. This was 
done to prevent subjects waiting, which would have caused a problem with the 
company management. Selection of a random sample of all subjects enrolled was not 
attempted, because of the uncertain date of attendance at follow-up visits and the time 
constraint. No individual refused participation. The questions were developed in 
English, with a Flesch-Kincaid grade level of 7.0 and a Flesch Reading Ease score of 
68 [116]. These “readability” scores were obtained using Microsoft Word version 6, 
and ai'e a measure of the educational level required to understand the language in a 
document. In this case, a grade level of 7.0 indicates that a person with seven years of 
formal education should understand the level of language in the docimient. It must be 
stated, however, that we have no such measure of the document in the language in 
which it was administered, Kiswahili. It was translated into Kiswahili by the Kenyan 
physicians and health educators, piloted in 30 subjects and finalised after holding 
focus group discussions with subjects at the clinics. The questionnaire was 
administered as a standardised interview, comprising four sections:
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$ General knowledge of prophylactic vaccines currently in use.
* The magnitude of the HIV-1 epidemic in Kenya, and perception of individual risk.
* Anticipated willingness to participate in an HlV-1 vaccine trial.
« Anticipated behaviour change resulting from such participation.
Standardised information regarding the nature and limitations of prophylactic vaccines 
was given after questions in the vaccine knowledge section, in order to resolve basic 
misconceptions. _
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Laboratory Methods: Studies 1 to 5
All specimens were transported to the laboratory at Coast Provincial General 
Hospital for processing. These laboratory methods were uniform in studies 1 to 5.
Sera were tested by synthetic peptide enzyme-linked immunosorbent assay 
(ELISA) for HIV-1 and HIV-2 antibodies (Belning Werke, Marburg, Germany). 
Positive samples were confirmed for HIV-1 using a recombinant ELISA system 
(Recombigen, Cambridge Biotech Corporation, Worcester, Massachusetts). Western 
blot assays (Cambridge Biotech Corporation, Worcester, Massachusetts) were 
performed if the two ELIS As produced discordant results, and to confirm all HlV-1 
séroconversions.
Serological testing for syphilis with rapid plasma reagin card test (RPR, 
Becton-Dickinson, Cockeysville, Maryland) and Treponema pallidum 
haemagglutination assay (TPHA, Becton-Dickinson, Cockeysville, Maryland) was 
carried out on all subjects at emolment. Active syphilis infection was defined by a 
positive RPR and TPHA. A negative RPR and positive TPHA provided evidence of 
past syphilis infection. RPR testing was performed at the 12 month follow-up visit, 
with TPHA confirmation if positive.
Gonorrhoea was diagnosed by positive culture of N  gonorrhoeae from uretlnal 
swab on modified Thayer-Martin media.
Non-gonococcal urethritis was defined by the presence of 5 or more 
polymorphonuclear cells per high power field (uretlrral inflammation) on a gram 
stained slide of urethral secretions, in the absence of N. gonorrhoeae infection.
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Genital ulcer disease was a clinical diagnosis, with no attempt made to 
differentiate ulcers caused by different aetiological agents on clinical grounds. H. 
ducreyi was cultured on activated charcoal media.
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Laboratory Methods: Study 6
A "first catch" specimen of 20 ml. of urine, collected at least two hours after 
men had last passed urine, was obtained and tested in the clinics by leucocyte esterase 
dipstick (LED, Boehringer-Mannheim). The dipsticks were read at 120 seconds as 
"negative", "trace", "1+" or "2+", according to the manufacturer's colour chart, and a 
positive LED test was defined as a reading greater than "trace". Urethral swabs were 
taken from all men, plated on modified Thayer-Martin media for A. gonorrhoeae 
culture, and placed in modified Diamond's media for T, vaginalis culture. The urine 
sample was transported in a cool box to the laboratory of the Coast Provincial General 
Hospital in Mombasa and centrifuged for 10 minutes at 3,000 rpm. The urine pellet 
was then re-suspended in one millilitre of supernatant, assayed for C. trachomatis by 
enzyme immunoassay (El A, Syva MicroTrak Chlamydia El A) and cultured for T. 
vaginalis by inoculation into modified Diamond's medium.
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Statistics
For cross-sectional comparisons, the Wilcoxon rank sum test was used to test 
differences for continuous variables and Pearson’s chi-square test and Fisher’s exact 
test for categorical variables.
Stata, version 3.0, was used for multivariate logistic regression analysis of 
determinants of urethral infection in Study 7. Multivariate Cox Proportional Hazards 
regression analysis to estimate hazard ratios for HlV-1 infection in Study 3, assuming 
uniform levels of exposure for risk variables for each individual throughout the period 
under study. Exceptions to this were when STDs were examined as time-dependent 
co-variates. An entry and removal (at p-value for adjusted hazard ratio greater than 
0.1) method was used in the construction of the models.
SPSS for Windows, version 6.0, was used to perform descriptive and 
comparative analyses, and S-Plus used for time-trend modelling techniques (Studies 4 
and 5). Generalised estimating equations with a binomial link and exchangeable 
coiTelation structure were employed for examination of changes in the sexual 
behaviour variables over time, and generalised estimating equations with a poisson 
link and exchangeable coiTelation structure were used to model changes in STD 
incidence [117]. Use of the exchangeable correlation structure was based on the 
assumption that there should be no difference over time in the correlation between 
observations made on the same man.
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Section 5: Results
Some discussion on the use of some of the study vai'iabies is included in this section, 
to aid understanding as the reader progresses through this section.
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Results 
Study 1: HIV 1 prevalence
A total of 1367 men were screened for antibodies to HIV-1 between March 1, 
1993 and January 31 1996, of whom 231 (17%) were seropositive. Nine hundred and 
fifty five HIV-1 seronegative men were eniolled in the prospective cohort study. Of 
the 181 (16%) seronegative men who were screened but not enrolled, 174 did not 
return for results. The remaining 7 men declined participation.
Seventeen percent (231/1367) of those screened were HIV-1 seropositive, but 
only 51% (118/231) of HIV-1 seropositive men were enrolled. As no data were 
collected on those not enrolled, it is not possible to confirm that this is a representative 
sample of the HIV-1 positive men.
HIV-1 seropositive men were older (33 vs 29), and consequently more were 
married (85% vs 63%). Although religion was not significantly associated with HIV- 
1 serostatus if examined as a 2 X 4 table, if moslem religion is examined against all 
others in a 2 X 2 table, the odds ratio for being HIV-1 seropositive and moslem is 0.52 
(95% Cl 0.28-0.93, p=0.02). The most mobile occupations (driver and assistant) were 
significantly more likely to be HIV-1 seropositive, but no such association was seen 
when the data was stratified by days of occupational travel. A lifetime history of sex 
worker contact or ever having used a condom were strongly associated with positive 
HIV-1 serostatus, as was increasing numbers of sex partners in the previous year.
The high percentage of uncircumcised men who were HIV-1 positive (26% vs 
13%) was highly significant (OR 2.43 [95%CI 1.51-3.91, p<0.001]).
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Table 5: Demographic, occupational, behavioural and medical characteristics at 
enrolment of all men, by baseline HIV-1 serostatus
HIV-1 Negative 
n=955
HIV-1 Positive 
n=118
p value
Demographic
Age, median (range) 29 (16-62) 33 (21-57) <0.001
Marital status
Married 599 (63%) 100 (85%) <0.001
Never married 345 (36%) 17 (14%)
Widorved / divorced 11 ( 1%) 1 (1%0
Years of education, mean (range) 9.1 (0-16) 9.0 (0-16) 0.1
Religion
Protestant 379 (40%) 51 (43%) 0.2
Catholic 303 (32%) 42 (36%)
Moslem 210 (22%) 15 (13%)
Other 63 ( 6%) 10 ( 9%)
Occupation
Driver 130 (14%) 32 (27%) 0.001
Assistant driver 210 (22%) 29 (25%)
Mechanic 237 (25%) 28 (24%)
Ancillary worker 376 (39%) 29 (25%)
Travel
No travel 531 (56%) 59 (50%) 0.3
<15 days/month 203 (21%) 24 (20%)
>15 days/month 221 (24%) 35 (30%)
Sexual behaviour
Lifetime
Age at first sex, median 15 16 0.5
History of sex with FSW 532 (56%) 95 (81%) <0.001
History of condom use 503 (53%) 79 (67%) 0.007
Past 1 year
Sex Partners
0 34 ( 4%) 0 <0.001
1 368 (39%) 21 (18%)
2-5 455 (48%) 75 (64%)
>5 98 (10%) 22 (19%)
Sex with FSW 297 (31%) 64 (54%) <0.001
Unprotected FSW sex 188 (20%) 48 (41%) <0.001
Sex with girlfriend or casual 
partner
522 (55%) 58 (49%) 0.3
Any unprotected extramarital sex 537 (56%) 76 (64%) 0.1
Used alcohol In past year 429 (45%) 61 (51%) 0.1
Uncircumcised 122 (13%) 31 (26%) <0.001
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Study 2: STD prevalence in Seronegative Men
The prevalence of active syphilis was 4.5% (43/955), and a further 2.6% of 
men (25/955) had evidence of past infection. The prevalence of symptomatic STDs at 
first presentation and association with occupational travel (>14 days a month), 
circumcision status, and an indicator of sexual risk behaviour, sex worker contact, are 
given below. Table 6 shows the number, percentage of the total, and age of men who 
presented with symptomatic STDs or serological evidence of active syphilis. Men 
with uretlii'itis included men with a positive gonorrhoea culture or who had five or 
more polymorphonuclear' cells per high power field on gram stain. Men with either 
diagnosis were significantly younger, while those diagnosed with syphilis were older. 
Overall, men with any STD were older, largely due to the number of men with 
syphilis.
Table 6: Mean age of HIV-1 seronegative men with and without STDs at first 
presentation
STD Number 
(% of all 
men)
Mean Age in years
Positive Negative p value
Urethritis 29 (3.0%) 27.5 30.4 0.05
GonoiThoea 20 (2.1%) 26.8 30.4 0.04
Genital ulcer 9 (0.9%) 32.0 30.3 NS
IT. ducreyi 4 (0.4%) 27.5 30.3 NS
Active Syphilis 43 (4.5%) 36.0 30.0 <0.001
Any STD 80 (8.4%) 32.0 30.1 .03
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Circumcision status was not significantly associated with any category of STD, as 
shown in Table 7.
Table 7; STDs in HIV-1 seronegative inert at first presentation, by circumcision status
STD Number 
(% of all 
men)
Circumcision Status
Circumcised
(n=833)
Uncircumcised
(n=122)
p value
Urethritis 29 (3.0%) 25 ( T0%0 4 (  3.3%) NS
Gonorrhoea 20 (2.1%) 16 ( 1.9%) 4 (  3 .4%) NS
Genital ulcer 9(0.9%0 7 ( 0.8%) 2 (  16%^ NS
H. ducreyi 4 (0.4%) 3 ( 0.4%) 1 ( 0.8%) NS
Active Syphilis 43 (4.5%) 36 ( 4.3%) 7 (  5.7%) NS
Any STD 80 (8.4%) 67: ( 8 4%0 13 (10.7%) NS
Occupational travel more than 14 days each month was used as a cut off 
between long-distance workers and short distance and sedentery workers. Two 
hundred and twenty one (23.1%) fell into the long-distance category. Table 8 details 
the associations between STDs and travel status. The urethral infections were both 
highly significant, as was syphilis, but genital ulcer disease was not, perhaps due to 
the small numbers.
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Table 8; STDs in HIV-1 seronegative men at first presentation, by occupational travel
STD Number 
(% of all men)
Occupational Travel
Lon^ distance 
(n=221)
No Long distance 
(n=728)
p value
Urethritis 29 (3.0%) 14 ( 6.3%) 15 ( 2.1%) <0.001
Gonorrhoea 20 (2.1%) 7 (  3 .2%) 13 ( 1.8%) <0.001
Genital ulcer 9 (0.9%) 5 ( 2.3%) 4 (  0.5%) NS
H. ducreyi 4 (0.4%) 2 ( 0.9%) 2 ( 0.2%) NS
Active Syphilis 43 (4.5%) 24(10.9%) 19( 2X%4) 0.002
Any STD 80 (8.4%) 43 (19.4%) 37 ( 5,1%) <0.001
At least one visit to a female sex worker was reported by 297 (31.1%) of 
seronegative men in the year prior to enrollment. This variable was significantly 
associated with every STD. All of the men with proven chancroid {H ducreyi) 
infection reported FSW contact. Although rmprotected sex worker contact was the 
behaviour variable which was most sensitive in the HIV-1 prevalence analysis, any 
reported FSW contact proved to be more significant for the STDs noted. This is 
represented in Table 9.
Table 9; STDs in HIV-1 seronegative men at first presentation, by reported 
sex worker contact
STD Number 
(% of all 
men)
^ex worker Contact 
in Previous Year
No
(n=658)
Yes
(n=297)
p value
Urethritis 29 (3,0%) 14 ( 2.1%) 15 ( 5 .1%) 0.02
Gonorrhoea 20 (2.1%) 9 (  1.4%) 11 ( 3 .7%) 0.02
Genital ulcer 9 (0.9%) 2 ( 0.3%) 7 ( 2,4%) 0.005
H. ducreyi 4 (0.4%) 0 ( 0%) 4 ( 1.3%) 0.01
Active Syphilis 43 (4.5%) 23 ( 3 .5%) 20 ( 6.7%) 0.03
Any STD 80 (8.4%) 39 ( 5 .90/ 0) 41 ( 13.8%) <0.001
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Study 3: HIV-1 incidence
There were a total of 40 séroconversions to HIV-1, in the course of 990 person 
years of follow-up (py) to January 1996, giving an overall HIV-1 seroincidence of 
4.0% per annum. Seventy five percent (716) of the 955 HIV-1 seronegative men 
enrolled contributed to follow-up. The full follow-up statistics are given in table 10. 
Men enrolled in the first 4 months contributed over half (496 person years) of total 
follow-up time, with a median follow-up time of 549 days. The subsequent 
enrolment quarter (3 months) yielded 174 person years or, 17.6% of total follow-up, 
decreasing thereafter.
The number of séroconversions and the person years of follow-up in each risk 
group are given in Table 11. The “moslem” variable, was included as potentially 
protective. Five (12.5%) séroconversions occurred in 299 person years in men who 
reported no partner other than a spouse, giving an incidence of 1.7 per 100 person 
years of follow-up. This was the group with the lowest incidence. Thirty five (88%) 
of séroconversions occurred in men who reported sex with a partner other than a 
spouse during follow-up. This group accounted for 70% of total follow-up time. 
Fourteen (35%) of séroconversions occurred in 21% of total follow-up time in men 
who reported unprotected sex with a sex worker.
The HIV-1 incidence rates, univariate and multivariate analysis of risk for the 
different variables are given in Table 12. The only variables which remained 
significant in the multivariate models were being a driver or driver’s assistant, 
reporting any extramarital sex during follow-up. For uncircumcised status, there was 
an adjusted hazard ratio of 2.0 (p= 0.1).
Table 10: Cohort follow-up statistics, by emolment quarter 81
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The sexual behaviour variable with the highest HIV-1 incidence was reported 
unprotected sex with a sex worker (6.7 per 100 person years), but the most significant 
variable in the multivariate model was any reported extramarital sex (5.1 per 100 
person years). However, men who reported any extramarital sex accounted for almost 
70% of the total follow-up time, compared to just over 20% for the men who reported 
unprotected sex worker contact. The same applies to the occupational travel variables. 
The driver or assistant (8.1 per 100 person years and 30% of total follow-up) and 
travel over 14 days a month (8.9 per 100 person years and 21% of follow-up) 
probably measure the same risk. Driver or assistant includes more men who go on 
shorter trips, can potentially return for better follow-up, and have an increased risk 
due to the exposure to risk behaviour which travelling away from home entails.
Table 11: HIV-1 séroconversions in risk groups, 
and follow-up time for each category
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Table 12: Analysis o f risk factors for HIV-1 seroconversion 84
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The STD incidence in seronegative men to January 1996, Avhich were included 
in the models, are detailed in Table 13, below.
Table 13; STD incidence in seronegative men.
STD Number of Cases Incidence
any genital ulcer 43 4.3 per 100 py
H  ducreyi 12 1.2 per 100 py
Treponema pallidum 4 0.4 per 100 py
gonorrhoea 131 13.2 per 100 py
non-gonococcal urethritis 50 5.0 per 100 py
The acquisition of genital ulcer disease is represented by "any genital ulcer". 
Ulcers which were H  ducreyi culture positive are included in this classification, but 
also presented separately.
It is recognised that the risk for men with genital ulcer and urethral discharge 
was not uniformly raised thi'oughout the study period, and that some men suffered 
from STDs while they were travelling, which we did not see at the clinic. However, 
the men most at risk of STDs, and not being seen at the clinic, aie the long-distance 
drivers and their assistants. This gave difficulty when uretlrral discharge and genital 
ulcers were examined as time-dependant covariâtes, because even approximate dates 
were difficult to obtain and there were often periods of six months or more between 
visits for such men. For this reason, STDs which were not observed were not 
included in the analysis.
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When observed urethr al discharges and genital ulcers were examined as time- 
dependent covariates with a six month inclusion period, no increase in the hazard 
ratios, or the precision of the measine of effect was noted. Univariate indices for 
genital ulcer moved to 2.0 [95% Cl; 1.0-4.2, p=0.05] and multivariate hazard ratio 1.3 
[95% Cl; 0.5-5.1, p=0.5]. The same pattern was seen for urethral discharge, with a 
univariate hazard ratio of 1.7 [95% Cl 0.9-3.2, p=0.1] and multivariate hazard ratio of 
1.1 [95% Cl; 0.5-2.9, p=0.5].
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Study 4: Behavioural risk reduction time trends
A total of 1195 men were screened for antibodies to HIV-1 between March 1, 
1993 and October 14, 1994, of whom 206 (17%) were seropositive. Eight hundred 
and fifty six HIV-1 seronegative men were enrolled in the prospective cohort study.
Of the 133 seronegative men who were screened but not enrolled, 126 did not return 
for results. The remaining 7 men declined participation. No demographic or risk 
profile characteristics are available from these 133 men.
Of those enrolled, 556 men returned for at least one follow-up visit. This 
represented 72% of 771 who were scheduled for follow-up on or before October 14, 
1994. Four hundred and ninety four person years (py) of follow-up were accrued, and 
1620 follow-up visits recorded. Mean follow-up was 326 days (range 21 to 588). The 
mean number of follow-up visits was 2.9 (range 1-8), and the mean interval between 
follow-up visits was 101 days (range 3-431).
There were no significant differences between men who did or did not return 
for follow-up with regard to median age (29 vs 29), unmarried status (35% vs 37%), 
median age at first sex (15 vs 15), lifetime history of sex with an FSW (57% vs 57%), 
median number of sex partners in the previous year (2 vs 2), or history of condom use 
(52% vs 55%). There was a significant difference in occupational travel, with 37% of 
those men who travelled more than two weeks each month failing to return for follow- 
up, compared with 25% of men who travelled two weeks or less each month
(p-0.001).
The em'olment demographic, occupational, behavioural, and medical 
characteristics of the 556 participating men are detailed in Table 14. The median age
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was 29 years and 63% were married. The majority of men had completed primary 
education. Almost half of the cohort travelled in the course of their work, often for 
extended periods of time. Over 50% reported a history of sex with an FSW and only 
51% had ever used condoms. Fifty nine per cent reported more than one sex partner 
in the previous year, and 20% reported unprotected sex with an FSW.
89
Table 14: Demographic, occupational, behavioural and medical characteristics at 
em'olment of seronegative men included in the time-trends study
Characteristics No. (%) 
Total = 556
Demographic
Age, median (range) 29 (16-62)
Marital status
Married 348 (63%)
Never married 199 (36%)
Widowed / divorced 9 ( 2%)
Years of education, mean (range) 9.1 (0-16)
Religion
Protestant 223 (40%)
Catholic 190 (34%)
Moslem 121 (22%)
Other 22 ( 4%)
Occupation
Driver 62 (11%)
Assistant driver 102 (18%)
Mechanic 172 (31%)
Ancillary worker 220 (40%)
Travel
No travel 299 (54%)
<15 days/month 142 (26%)
>15 days/month 115 (21%)
Sexual behaviour
Lifetime
Age at first sex, median 16
History of sex with FSW 314 (57%)
History of condom use 286 (51%)
Past 1 year
Sex Partners
0 19 ( 3%)
1 213 (38%)
2-5 270 (49%)
>5 54 (10%)
Sex with FSW 168 (30%)
Unprotected FSW sex 109 (20%)
Sex with girlfriend or casual 
partner
311 (56%)
Any unprotected extramarital sex 309 (56%)
Used alcohol In past year 262 (47%)
Uncircumcised 72 (13%)
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During follow-up, 53% (184) of married men reported extramarital sex, 42% 
(145) unprotected (without condom) extramarital sex , 20% (71) FSW sex, and 16% 
(54) unprotected FSW sex. One hundred and fifty two (44%) maiTied men reported at 
least one three month period when they did not have sex with their wife, and they 
were significantly more likely to report sex with another partner during these periods 
(OR 2.5: 95% Cl 1.8-3.4, p<0.001) or acquire an STD (OR 4.9: 95% Cl 2.7-8.7, 
p<0.001). Eighty six percent (178) of unmanied men reported sex with any partner, 
73% (152) unprotected sex, 27% (55) sex with an FSW, and 15% (32) unprotected sex 
with an FSW. No sex with a male partner was reported.
Of the 126 men who reported sex with an FSW, 46 (36%) never used 
condoms, 40 (32%) sometimes used condoms, and 40 (32%) consistently used 
condoms. One hundred and fifty nine (49%) of 323 men who reported sex with a 
girlfriend never used condoms, 116 (36%) sometimes used condoms, and 57 (18%) 
consistently used condoms. Significantly more men reported consistent condom use 
with FSWs than with girlfriends (p=0.002). Overall, condoms were used for 27% of 
sex acts with girlfriends and 50% of sex acts with FSWs.
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There were significant declines in the percentage of men reporting 
extramarital sex or sex with an FSW during the prior 3 month period, as shown in 
Table 15 and Figure 4. Statistical modelling indicates that the percentage reporting 
extramai'ital sex decreased from 49% during the first quarter to 36% during the last 
quarter of follow-up (p<0.001). The analogous decline for sex with an FSW was from 
12% to 6% (p=0.001). To determine if loss to follow-up was causing biased results 
(e.g. differential loss to follow-up of men with higher levels of risk behaviour would 
produce an aitifactual decline), we modelled separately the trends in sexual behaviour 
of men who attended <75% and >75% of their scheduled follow-up visits. In both 
subgroups, there were significant reductions in the percentage of men reporting 
extramarital sex (p=0.02 and p=0.006, respectively) and FSW sex (p=0.02 for both).
These declines in high risk sexual exposure were not 
accompanied by changes in condom use. As shown in Figure 4, the percentage of 
men who reported consistent (100%) condom use during extramarital sex remained 
fairly constant at approximately 30% (p=0.5). Men with <75% and >75% follow-up 
compliance had similar rates of consistent extramarital condom use, and no significant 
changes were observed over time (p=0.2 and p=0.9 respectively). Average frequency 
of condom use and the percentage of men who reported ever using condoms with any 
partner type also remained stable over time.
Table 15. Proportion of men in time-trends study with; 
selected sexual behavioural variables, by quarter of follow-up
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Figure 4: Sexual behaviour and condom use during follow-up in time-trends study 93
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Study 5: STD incidence time-trends
In the course of follow-up for the time-trends studies, there were 20 
séroconversions to HIV-1 (4.0/100 py), 62 cases of gonorrhoea (12.6/100 py), 37 
cases of non-gonococcal urethritis (7.5/100 py), and 35 cases of genital ulcer disease 
(7.1/100 py), including 7 which were H. ducreyi culture positive. One incident 
syphilis infection was seen (0.3/100 py). Histories of an additional 117 episodes of 
uretliral discharge and an additional 3 8 cases of genital ulcer disease which occuiTed 
between clinic visits were recorded. Men who travelled more than two weeks each 
month had significantly more STDs than those with less occupational travel (risk ratio 
1.9: 95% Cl 1.5-2.6, p<0.001).
Change in incidence of STDs during follow-up quarter are shown in Figure 5 
and Table 16. There was a decrease in the modelled incidence of observed STDs from 
34 cases per 100 py during the first quarter to 10 cases per 100 py during the last 
quarter of follow-up (p=0.001). Similar declines were seen when each of the STDs of 
interest (gonorrhoea, non-gonococcal urethritis, and genital ulcer disease) were 
modelled separately or when seif-repoited STD symptoms (uretlrral discharge or 
genital ulcers) occurring between clinic visits were added to the model (p<0.001).
The incidence of observed STDs underwent significant reductions in men with <75% 
follow-up compliance (from 20% to 4%, p=0.05) and >75% follow-up compliance 
(from 47% to 11%, p=0.001). No significant time trends were discernible with 
respect to HlV-1 seroincidence, but the statistical power of this study was insufficient 
to definitively address this issue.
Table 16. Incidence of STDs in time-trends study, 
by quarter of follow-up
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Figure 5: STD incidence during follow-up in time-trends study 96
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Study 6: Urethral infection study
Demographic, occupational, behavioural and circumcision characteristics of 
the 504 men did not differ significantly from those in table 5. HIV-1 positive men 
were included in this analysis. The mean age was 30 years and they had a mean of 9 
years of education. Almost three-quarters of the men were mairied, 73% were 
Cliristian and 19% were Muslim. Thirty-tliree per cent were drivers or drivers’ 
assistants, and 22% travelled for more than two weeks each month in the course of 
their work. Over half of the men reported having ever paid for sex, having ever used 
condoms, and having had an STD at least once in the past. In the previous three 
months, 37% of married men reported sex with a pailner other than their wife, and 
20% reported more than one sex partner. Sixty per cent of mamed men had spent less 
than half of the previous month living with their wife. Fifteen per cent of men were 
uncircumcised, 8% had serological evidence of past or current syphilis infection 
(positive TPHA), and 15% tested positive for antibodies to HIV-1.
Table 17 indicates the pathogens which were identified, stratified by 
presenting symptoms. Over 11% of men had at least one urethral pathogen detected. 
Four per cent of men had a symptom of urethral discharge and 5.4% had a symptom 
of dysuria alone. The remainder (90.7%) were asymptomatic. Seventy per cent of 
men with urethml discharge, 22.2% of men with dysuria and 8.3% of asymptomatic 
men had at least one uretlrral pathogen identified. However, because most men were 
asymptomatic, the majority of infections (about two-thirds) occurred in asymptomatic 
men. T. vaginalis infection was found in 15% of symptomatic men (uretlrral discharge 
and/or dysuria), 5% of asymptomatic men, and 6% of men overall. Urethml infection 
rates did not differ significantly between drivers and non-driving ancillary workers. 
Mean age was significantly lower in men with goirorrhoea compared to those without
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gonorrhoea (25.0 vs 30.0 years, P = 0.006), whereas there was a strong trend towards 
older age in men infected with T. vaginalis (32.2 vs 29.9 years, P -  0.06).
Table 17. Prevalence of nretlnal infections, stratified by symptom (N=504).
Pathogen Symptom of
urethral
discharge
Symptom of 
dysuria alone 
(no discharge)
Asymptomatic Prevalence 
of uretlu'al 
infection
N -20 (4.0%) N=27 (5.4%) N=457 (90.7%) N=504 (100%)
Neisseria gonorrhoeae 
(Ng), by urethral swab 
culture
8 (40%) 2 (7.4%) 5(1.1%) 15(3.0%)
Chlamydia trachomatis 
(Ct), by El A on urine
2 (10%) 1 (3.7%) 10 (2.2%) 13 (2.6%)
Trichomonas vaginalis 
(Tv), by urethral swab 
culture
2 (10%) 2 (7.4%) 19 (4.2%) 23 (4.6%)
Ng & Tv 
(mixed)
1(5%) 1 (3.7%) 0 2 (0.4%)
C t & T v
(mixed)
1(5%) 0 4 (0.9%) 5 (1.0%)
Total 14 (70%) 6 (22.2%) 38 (8.3%) 58(11.5%)
There was considerable discordance between those men with a symptom of 
urethi’al discharge and those who were found to have discharge on physical 
examination (Table 18). In the overall population, of the 20 men with the symptom of
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uretlii'al dischai'ge, only 10 had discharge on physical examination, and of 22 men 
among whom discharge was elicited on physical examination, only 10 had given a 
complaint of discharge. Among the 58 men with confirmed urethr al infection, there 
were 14 who had a symptom of uretlrral discharge. Of these, only 9 (64.3%), had 
evidence of a discharge on physical examination.
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Table 18. Agreement between the complaint of metlrral discharge and the finding of 
urethral discharge on physical examination.
Complaint of discharge 
Yes No Total
Yes 10 12 22
Discharge on
physical No 10 472 482
examination
Total 20 484 504
B. Among men with confirmed urethral infection
Complaint of discharge 
Yes No Total
Yes 9 3 12
Discharge on
physical No 5 41 46
examination
Total 14 44 58
Table 19 shows the performance parameters of the LED test in symptomatic 
and asymptomatic men. For symptomatic men, treatment based on a positive LED 
test would pick up 95% of infections. With a positive predictive value of 63%, 37% of 
LED positive men would be treated unnecessai'ily. By contrast, if management were 
based on treating all symptomatic men, 57% would be treated umiecessarily, although
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of course 100% of infections in this group would be picked up. Among asymptomatic 
men being screened, treatment based on a positive LED test would pick up 55% of 
infections. Of those treated, 77% would be treated unnecessarily. The three men 
with confirmed urethr al infection who did not complain of discharge, but had 
discharge on physical examination (Table 19), all had positive LED tests.
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Table 19: Performance parameters of the leucocyte esterase dipstick (LED) test by 
symptom group.
Any urethial 
Infection 
(Ng, Ct or Tv)
Symptomatic men 
(urethral discharge 
and/or dysui'ia)
Asymptomatic men All men
LED positive 63.8% 20.4% 24.4%
( > trace) (30/47) (93/457) (123/504)
Sensitivity 95.0%
(19/20)
55.3% (21/38) 69.0% (40/58)
Specificity 59.3%
(16/27)
82.8% (347/419) 81.4% (363/446)
Positive predictive 
value
63.3%
(19/30)
22.6% (21/93) 32.5% (40/123)
Negative predictive 
value
94.1%
(16/17)
95.3% (347/364) 95.3% (363/381)
If asymptomatic men with an LED equal to trace were included as positive, 
83% (379/457) would be considered positive, 
viii) Strategies for Control of Uretlrral Infection
Table 20 compares how tluee potential detection and treatment strategies for 
uretlii'al infection would have performed in this population. Strategy 1, treatment on 
the basis of presenting symptoms, is the strategy used in most treatment settings in 
Africa. Strategy 2, treating only men who present with discharge and whose 
discharge is confirmed on physical examination, is a strategy that is advocated by 
many medical practitioners, and is the one recommended in World Health
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Organisation (WHO) treatment guidelines [58]. Strategy 3 is a combination of 
Strategy 1 for symptomatic men, with use of the LED test for asymptomatic men.
Note that Strategy 1 (treatment based on symptoms alone) was more than twice as 
sensitive as treatment requiring both symptoms and signs of discharge to be present 
(Strategy 2). Strategy 2 was highly specific, but at the price of low sensitivity. The 
highest sensitivity was obtained using Strategy 3, although this strategy did not 
perform significantly better than using the LED test alone.
Table 20: Perfomiance parameters of potential strategies for detecting and 
treating urethral infection.
Treatment
strategy
Strategy 1 :
Treat only men with 
symptoms (uretlual 
discharge and/or 
dysuria)
Strategy 2:
Treat only men with 
uretlrral discharge that is 
confirmed on 
physical examination
Strategy 3:
Treat all men with 
symptoms (uretlrral 
discharge and/or dysuria), 
and asymptomatic 
men with a positive LED 
test
Sensitivity 34.5% 15.5% 70.7%
(20/58) (9/58) (41/58)
Specificity 93.9% 99.8% 77.8%
(419/446)) (445/446) (347/446)
Positive 42.6% 90.0% 29.2%
predictive
value
(20/47) (9/10) (41/140)
Negative 91.7% 90.1% 95.3%
predictive
value
(419/457) (445/494) (347/364)
Potential behavioural risk factors for predicting uretlrral infection were explored by 
means of multiple logistic regression, as we wished to examine whether a risk score 
could be constructed that would improve diagnostic accuracy. The regression model 
used proven infection as the dependent variable, and signs, symptoms, LED test, age, 
and behavioural variables as independent variables. LED positivity was the predictor 
with the highest adjusted odds ratio (OR = 6.8, 95% Cl 3.3 -14.0), followed by the
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presence of symptoms of urethral discharge and/or dysui'ia (OR ^  3.2, 95% CÏ 1.4 - 
7.3), and uretlu'al discharge on examination (OR = 3.0, 95% Cl 1.0 - 9.0).
Extramarital sex, commercial sex, unprotected sexual contacts, occupational travel 
and age were not associated with urethral infection. Non-cohabitation with a spouse 
for more than half the previous month was also not significantly associated with 
urethral infection. However, when infections were analysed separately, recent non­
cohabitation with a spouse was associated with C. trachomatis and/or N. gonorrhoeae 
infection (adjusted OR = 5.4, 95% Cl 1,2 -24.4), but not with T. vaginalis infection.
Differences between the results of HIV-1 positive nad negative men were also 
sought. A significantly higher number of HIV-1 positive men (21/75, 28%) had 5 or 
more urethral polymorphs per high power field on gram stain than HIV-1 negative 
men (79/429, 18%), OR 1.7 (1.0-3.0, p=0.05). HIV-1 positive men had a higher mean 
number of sex partners in the tlii'ee months prior to examination (1.28 vs 1.02, 
p=0.02). STD prevalences and odds ratios are outlined in Table 21.
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Table 21: Urethi*al infection by HIV-1 serostatus.
STD HIV-1
positive
HIV-1
negative
OR (95% Cl) p value
any STD 11/75 (15%) 47/429 (11%) 1.4 (0.7-2.8) 0.4
Ng 4/75 (5%) 13/429 (3%) 1.8 (0.6-5.7) 0.2 FET*
Ct 5/75 (7%) 13/429 (3%) 2.2 (G.8-6.6) 0.1 FET
Tv 5/75 (7%) 25/429 (6%) 1.2 (0.4-3.1) 0.8 FET
*FET, fishers exact test
No significant differences in STD prevalence was detected between HIV-1 positive 
and negative men.
Age, presence of urethritis on uretlrral swab gram stain and urine leucocyte 
esterase urine dipstick (LED) results of men with unmixed infections with Tv, 
Neisseria gonorrhoeae (Ng), Chlamydia trachomatis (Ct), or no infection are given 
in table 22. Results from both symptomatic and asymptomatic men are included in 
the table, but seven men with mixed infections have been excluded.
Men with positive Tv culture were significantly older than men with Ng 
infection (p=0.003). Eighty thr ee per cent (19/23) of Tv infections which were Ng 
culture and Ct enzyme immunoassay negative were asymptomatic. However, 37% 
(7/19) of these men had urethritis, defined as > 5 polymorphonuclear cells (PMNs) 
per high power field, and 42% (8/19) were LED test positive (greater than trace).
Both of these findings were significantly higher than asymptomatic men with no 
uretlu'al pathogen isolated, of whom 16% (66/419) met the criteria for uretluitis (odds 
ratio [OR] 3.1: 95% confidence interval [Cl] 1.4-8.2, p=0.02), and 17% (72/419) were 
LED test positive (OR 3.5: 95% Cl 1.4-9.0, p<0,01). Only one of the four men with
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symptomatic unmixed urethral Tv infection met the criteria for uretluitis, but all four 
were LED positive.
Table 22: Age, presence of urethritis and LED status of men with uretlual infection
Pathogen Isolated 
(Unmixed Infections 
Only)
Number 
of men
Mean Age 
(95% Cl)
Uretluitis on 
gram stain 
(>5 PMNs per 
high power field)
Urine LED 
positive 
(> trace)
7! vaginalis 23 32.3 (28.4-35.7) 8 (35%) 13 (50%)
N. gonorrhoeae 15 24.7 (22.7-27.0) 12 (80%) 13 (93%)
C. trachomatis 13 29.2(23.8-31.6) 3 (23%) 9 (69%)
No pathogen 446 29.9 (29.3-30.5) 73 (16%) 83 (19%)
Thirty three percent (5/15) of unmixed Ng infections were asymptomatic with 60% 
(3/5) meeting the criteria for urethritis while 80% (4/5) were LED positive, and 77% 
(10/13) of single Ct infections were asymptomatic with 20% (2/10) positive for 
uretluitis and 70% (7/10) LED positive.
T. vaginalis accounted for about 45% of all unmixed urethral infections. It 
was largely asymptomatic, as only 4 of 23 unmixed T. vaginalis infections were 
associated with discharge and/or dysuria. Men with T. vaginalis were older than men 
without the organism. C. trachomatis accounted for about 25% of all unmixed 
infections, and was also largely asymptomatic. Conversely, N, gonorrhoeae, 
accounting for about 30% of all unmixed infections, was mainly symptomatic and 
associated with younger age.
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Study 7: HIV-1 vaccine acceptability survey
The demographic and behavioural characteristics of respondents are described 
in Table 23.
Table 23. Demographic and Behavioral Characteristics of Participants on the Vaccine 
Acceptability Survey
Mean / median 
or proportion (%)
Male Trucking Company Employees (n = 201)
Age (mean, years) 30 (range 17-54)
Years of formal education
None 3 (2%)
0 - 7 53 (26%)
>8 145 (72%)
Occupation
Truck drivers or assistants 41 (20%)
Mechanics 73 (36%)
Ancillary workers 87 (43%)
Religion
Protestant 76 (38%)
Catholic 66 (33%)
Moslem 50 (25%)
Marital status
Married 121 (60%)
Unmarried 75 (37%)
Widowed or divorced 5 (3%)
History of sex with a FSW 105 (52%)
History of condom use 102 (51%)
Sexual behavior past year
2 - 5  sex partners 95 (47%)
>5 sex partners 23 (11%)
Unprotected sex with a FSW 44 (22%)
Sixty percent of the men were married. Fifty eight percent reported two or 
more sex partners and 22% gave a history of unprotected sex with a FSW in the year 
prior to enrolment. One hundred and forty five men (72%) had completed primary 
education (8 year's). The only statistically significant difference between the cohort as 
a whole and the sample participating in the vaccine acceptability survey was in the
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percentage of truckdrivers and their assistants. These more mobile occupations made 
up 36% of the total male cohort, but only 20% of the sample surveyed (p<0.001).
Knowledge of respondents regarding vaccines cuiTently in use in Kenya is 
shown in Table 24. Eighty six percent (86%) of the men knew that vaccines are used 
to prevent disease and 88% were able to name a vaccine preventable disease. 
However, less than half knew that vaccines were not 100% efficacious and less than 
one third knew that vaccines could have adverse effects. There were no statistically 
significant differences in any of the responses by educational level.
Table 24. Knowledge of Vaccines Currently in Use in Kenya
Men (ii = 201)
Knew that vaccines are used to prevent disease 173 (86%)
Were able to name a vaccine preventable disease 176 (88%)
Knew that vaccines were not 100% efficacious 98 (49%)
Knew that vaccines could have side effects 58 (29%)
One hundred and ninety one (95%) men thought that HIV infection and AIDS 
was a major problem in Kenya, and only 29 (14%) men felt at no personal risk of HIV 
infection.
Replies to questions regaiding acceptance of a safe and efficacious HIV-1 
vaccine, acceptance of the likely conditions of a vaccine trial, and acceptance of 
participation in a vaccine trial are given in Table 25.
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Table 25. Acceptance o f Conditions of an HIV-1 Prophylactic Vaccine Trial
Men (n = 201)
Yes Perhaps No
Would accept an HIV vaccine of 
known high safety and efficacy
186 (93%) 8 (4%) 7 (4%)
Would accept a double blind, 
placebo controlled design
137 (68%) 30(15%) 34 (17%)
Would accept a follow-up 
of 3-5 years
129 (65%) 34(17%) 34(17%)
Would accept a "false positive" 
HIV serologic result
132 (66%) 34 (17%) 33 (16%)
Would participate in trial of a 
candidate HIV vaccine
133 (67%) 35 (18%) 32(16%)
Only 4% of said they would refuse an HIV-1 vaccine of known high safety 
and efficacy. The reasons given for refusal included the fear of acquiring HIV-1 
infection from the vaccine (7 men), no perceived risk of infection (2 men). Sixty 
seven per cent of men said they would definitely agree to participate in a trial of a 
candidate HIV-1 vaccine given the conditions specified, and an additional 18% said 
they would possibly participate. Concerns regarding participation included fear of a 
positive HIV blood test result (27 men), fear of HIV infection from the vaccine (11 
men), prolonged follow-up period (2 men), and fear of injections (1 man). There was 
no significant effect of educational level on vaccine trial.
Anticipated sexual behaviour changes as a result of participation in an HIV-1 vaccine 
trial are shown in Figure 6. Seventeen (9%) men said that they would decrease 
condom use, and 18 (9%) would increase numbers of sex partners. Two men stated 
that they would do both. Anticipated higher risk behaviour was not significantly 
associated with age, years of education, history of unprotected sex with FSWs.
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Section 6: Discussion and Conclusions
I l l
Discussion
The research which is the subject of this thesis has been carried out to 
contribute to efforts to mitigate the effects of the HIV-1 pandemic in the developing 
world. The sexual risk reduction work (Studies 4 and 5) has been chosen as one of 
only two selected examples of evaluated interventions to prevent HIV-1 in male 
groups in developing countries, in a World Bank Policy Research Report aimed at 
policymakers “who shape the public response to HIV/AIDS to design an effective 
strategy for confronting the epidemic” [118]. The uretlual infection data (Study 6) 
contributed to a meeting of international public health policymakers, chaired by 
WHO, on the future shape of the STD algorithms, held at the Eleventh Meeting of the 
International Society for STD Research in New Oiieans[l 19]. Specific aspects 
discussed were the use of symptoms rather than signs of male uretlual infection and 
the potential inclusion of Trichomonas vaginalis therapy in the male urethritis 
algorithms. A list of publications in international peer-review journals from this 
cohort is included before the reference section.
Many of the subjects which have been explored have inter-linked issues. An 
attempt is made to try to separate these issues for the purposes of discussion.
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Circumcision Issues
It is biologically plausible and consistent with current knowledge, that 
uncircumcised men are at increased risk of acquisition of HIV-1 infection during 
sexual intercourse. There was insufficent statistical power to show a significant 
difference in HIV-1 acquisition between circumcised and uncircumcised men, 
because of insufficient numbers of uncircumcised men and insufficiently high HIV-1 
seroincidence. With an adjusted hazard ratio of 2.0, an HIV-1 incidence of 6.0% in 
uncircumcised men, and only 13% of the study population uncircumcised, a total 
study population of 3,344 would have been required to have 80% power to show a 
significant difference, at the 5% level (p<0.05) within the study timeframe. This 
would have required a different scale of operations and funding structure.
Although the study did not have the power to show a significiant difference in 
HIV-1 acquisition between circumcised and uncircumcised men in 990 person years 
of follow-up, it provides evidence which is supportive of male circumcision as an 
intervention against HIV-1 infection. Even if it does not become statistically 
significant in the final analysis, it will add to the body of knowledge on this subject, 
by contributing to databases from different centres and being used in meta-analyses.
The principal tribe in Kenya which does not practice circumcision are the Luo. 
The tribal area of the Luo is on the banks of Lake Victoria, in Nyanza Province, 
western Kenya [3]. This means that a higher percentage of uncircumcised men in 
Mombasa are migrant workers, as the coastal tribes and etlmic groups all practice 
circumcision. The women who become the sex partners of the men who work away 
from home are often bar workers [4]. The man will give some money to help look 
after the womans' children or pay the rent. Sex is being traded, but the man may not
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view the woman as a sex worker but as a girlfriend, because no straight cash-per-sex- 
act transaction is entered into. In this way, more uncircumcised men may be at risk of 
HIV-1 infection, despite not reporting FSW contact. This will be discussed further in 
the appropriate section.
For that reason, it may be that Mombasa was not, geographically, the best 
place to examine the relationship between circumcision and HIV-1 infection. The 
probability is that the majority of uncircumcised men had poorer access to their wives 
and families than the majority of circumcised men [44]. Also, if a man returns home 
to Eastern Province and has sex with a girlfriend, his level of risk is less than a man 
who returns to Nyanza, where the background seroprevalence is more than double 
[22]. In this way, it is probable that lack of male circumcision contributes to a 
positive feedback loop in which increased individual susceptibility of a significant 
proportion of the population gives overall increased transmission rates, which leads to 
increased background seroprevalence, and consequently higher transmission rates.
The extent to which any increased susceptibility to HIV-1 is mediated through 
other genital ulcer disease is unknown, and has not been answered by this cohort, due 
to the factors outlined above and relatively low GUD incidence (4.3/100 py).
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Migration and Sex Partner Issues
Men who travel in the course of their work follow regular trade routes and 
may have "girlfriends" in many towns, and the women may, in turn, have more than 
one regular' sex partner who helps them with living costs. In this way men may have 
very high risk contacts without telling us, and without attempt to deceive. Supporting 
evidence for this exists in the relationship between confirmed H  ducreyi infection, 
chancroid, and unprotected FSW contact (Table 9). Chancroid is a painful genital 
ulcer disease of relatively shoi't infectious duration (see introduction). For this reason, 
high rates of pai'tner change are required to sustain the infection in the community, 
and infection is characteristically associated with recognised FSW contact [120]. In 
one Nairobi study, 66% of men with chancroid reported a paid sex partner as the 
source of infection [121]. Another potential reason for occupational travel being an 
independent risk factor is that the prevalence of STDs in towns which are truckstops 
is very high, increasing the risk involved in any sexual encounter [104]. Mgalla and 
Pool examined the structure of informal sex work female bar workers in north-west 
Tanzania [4]. They found that the distinction between regular and casual partners was 
in the nature and extent of financial support, and the women stated that they could 
demand condom use from casual partners, but not from regular partners. These 
regular partners were often itinerant workers and truck drivers.
In this cohort, men who reported sex with their wives in the previous tliree 
months were less likely to seek other partners, and almost five times less likely to 
become infected with a symptomatic STD. Adult male rural to urban migration has 
become a feature of life in many developing countries. While the economic root 
causes of this migration cannot be addressed by health or education sectors alone, the
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structure of adult male interventions should incorporate specific strategies to access 
migrant labourers, as they often are clients of FSWs, an important urban male STD 
core group, and a source of spread of STDs and HIV-1 to rural areas [105].
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Sexual Behaviour and STD Issues
Several limitations of the STD incidence and time-trend studies should be 
noted. The time-trend studies included STD evaluation only for symptomatic men, 
and hence provided an underestimate of STD incidence. As we have seen in the 
appropriate section, asymptomatic urethral infection is common. It is unclear the 
extent to which these asymptomatic infections increase susceptibility to HIV-1 
infection, or transmission of HIV-1 to sex partners, but in fiiture studies it would be 
valuable to monitor changes in both symptomatic and asymptomatic STDs. This 
study included only HIV-1 seronegative men, but the evaluation of behavioural 
interventions among HIV-1 seropositive men would be of great public health 
importance. Also, the reported changes apply to a selected group of HIV-1 
seronegative men, as there were men who were screened but not emolled, and almost 
30% of men who did not contribute to follow-up. Although men who did and did not 
return for follow-up were similar for baseline characteristics except for occupational 
travel, it is possible that our results suffered from bias.
The application of time-dependent covai'iates was unhelpful in identifying any 
relationship between incident HIV-1 infections and incident STDs. Potential reasons 
for this ai’e that only men with symptoms who were available to attend the clinics 
were sampled, and the information collected on the timing of any STD between clinic 
visits was insufficiently precise. The fact that STDs were positively associated with 
HIV-1 acquisition on univariate analysis may merely be acting as a marker for higher 
risk sexual behaviour.
No baseline HlV-1 risk perception was done, so no information was available 
on personal assessment of risk of HIV-1 infection before enrolment and counselling.
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but the vaccine acceptability survey carried out during follow'-up revealed that 86% of 
men felt at some degree of personal risk of AIDS. This compares with only 8% of 
men with genital ulcer disease who were surveyed at an STD clinic in Nairobi in 1991 
[121]. In that study, the factor most significantly associated with perception of 
personal risk was acquaintance with a person with AIDS. It is probable that the high 
perception of personal risk of HIV-1 infection in our cohort played a significant role 
in decreasing risk behaviour [122]. As the effects of the epidemic become more 
widespread, the proportion of the general population with personal knowledge of 
AIDS tlii’ough illness in a family member or friend will increase. This is likely to 
increase the receptivity of men to education and risk reduction counselling, potentially 
leading to behaviour change.
The absence of reported increases in condom use in any group in the cohort, 
despite active condom promotion and open access to unlimited free supplies, is a 
cause for concern, and a subject requiring further examination. Condom use varied 
significantly with different categories of sex partner in this study. Our results are 
consistent with those of a study of truck drivers in Tanzania which found that men 
were less likely to use condoms with regular partners, whom they classified as "safe" 
[123]. This sense of security in men decreases the power of women to negotiate 
condom use, as they may be economically dependent on regular partners, as outlined 
by Mgalla and Pool, referenced above. Another study of factory workers in Tanzania 
reported no increase in overall condom use, but increased use with casual partners
[57]. Men in the Mombasa study were more likely to use condoms with sex partners 
they classified as sex workers than with partners they classified as girlfriends. While 
condom use did not rise over time, percentage use was higher at baseline than in
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Tanzania, with around 30% of extramarital sexual contacts from this cohort covered 
with condoms, compared with under 10% in the Tanzanian cohort.
Reported condom use increased in studies of HIV-1 discordant couples in 
Rwanda and Zaire, after an intervention of HIV-1 serotesting and counselling 
[124,125]. It is likely that the HIV-1 screening itself played a role in behaviour 
change in our cohort but, as we did not follow the men before serotesting, it is not 
possible to quantify that role. Our results highlight the difficulty in changing sexual 
behaviour of individuals once patterns have been established. Providing adolescents 
with condom handling and negotiation skills could facilitate condom negotiation for 
both males and females at the commencement of sexual activity, and in the long term 
a generation of peer health educators and positive role models might be created.
This study shows that a climate favourable to behaviour change currently 
exists in this cohort of east-African men. How this climate can best be exploited to 
full benefit on a larger scale could be evaluated by randomised, controlled trials of 
programmes that include counselling, condom promotion, and service delivery 
systems in different occupational and community groups. The extent of study effects, 
cohort attrition, and return to high risk behaviour could also be fully addressed in that 
context. In addition to behavioural intervention efficacy trials, identification of the 
most effective points of access and examination of cost-effectiveness issues should be 
carried out in order to ensure replicability. Exploration of partnerships with industry 
and private sector employers might be possible, with intervention programmes paid 
for by industry, if they could be persuaded that a programme would be economically 
advantageous in the long term.
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Even if a safe and efficacious HIV-1 preventive vaccine were to be developed 
soon, it would be overly optimistic to expect that HIV-1 and STD transmission will be 
controlled in the near future. The need to effectively address the issue of sexual 
safety in both adults and adolescents in both urban and rural areas is urgent, especially 
in developing countries, where decisions on sexual relationships are often dominated 
by economic imperatives.
This was the first published study of uretlu'al infection, including T vaginalis, 
in asymptomatic men in a workplace population, worldwide. Over 90% of men were 
asymptomatic, as were two-thirds of the infections identified, and these would have 
been missed by passive case finding. There was clearly an enormous burden of 
sexually transmitted infections in this population, despite the fact that the uretlrral 
infection study directly followed a documented decrease in risk behaviour and 
symptomatic STDs.
T. vaginalis has generally not been given much consideration as a urethral 
pathogen among men in developing countries. However, as T, vaginalis has been 
detected in vaginal specimens from upwards of 40% of general populations of women 
in Africa [126,127], it should not be surprising to find it in high levels in men as well.
Increased shedding of human immunodeficiency virus type 1 (HIV-1) in 
semen in the presence of urethi al infection and uretlu itis has recently been described 
in Malawi [78]. In that study, men with Tv urethial infection were observed to 
have significantly increased HIV-1 shedding in semen. In light of the results from 
Malawi, there are several points worth making:
1. Absence of symptoms does not necessarly imply absence of urethiitis, especially in 
the presence of Tv or Ct infection.
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2. The association of higher prevalence of Tv infection with older age is unusual for a 
sexually transmitted disease, and suggests that infection may be of long duration.
3. Tv infection is associated with less severe symptoms than Ng infection and leads 
fewer men to seek treatment. In addition, even among symptomatic men, guidelines 
for syndromic management regimens for urethial discharge do not generally include 
treatment for Tv, so even if a man seeks treatment, he is unlikely to be adequately 
managed (see figure 3).
4. Tv infection has not featured highly in projections of population attributable risk 
fractions for HIV-1 infection associated with various STD pathogens. However, Tv 
infection is very common among women, as evidenced by a community study from 
Uganda which described a Tv infection prevalence of 47% in rural women[127]. Tv 
is probably more common among men than is generally appreciated, and long­
standing, low-grade urethritis may lead to an increased risk of male-to-female 
transmission of HIV-1.
5. Further study into the role of Tv in HIV-1 transmission is warranted. If Tv does 
significantly enhance HIV-1 transmission, mass treatment strategies for Tv infection 
could potentially play a valuable part in HIV-1 prevention in developing countries, as 
an effective single-dose, low cost treatment for Tv (Metronidazole 2gm) is available 
worldwide.
Previous evaluations of the LED dipstick test in men have measured 
performance in detecting N. gonorrhoeae and C. trachomatis only. Sensitivities 
among asymptomatic men in North America have ranged from 41% to 100%, 
specificities from 83% to 96%, and positive predictive values from 20% to 58% 
[74,80-82]. The LED test in this study showed great promise. Used alone as a
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predictor of urethral infection, it had a much higher sensitivity than did the presence 
of symptoms, albeit with a lower specificity. Among symptomatic men, it picked up 
95% of infections, while excluding 59% of those without infection, consequently 
reducing the amount of unnecessary treatment that would occur if all men with 
symptoms were treated. It could thus be usefiil in the clinical management of 
symptomatic men in sub-Saharan Africa: with the high sensitivity and negative 
predictive value in symptomatic men, few infections would be missed, while the 
number of men treated unnecessarily and the subsequent drug costs would be reduced. 
Among asymptomatic men, the LED test had a sensitivity of over 50% and a 
specificity of over 80%, far from perfect performance, but easily the best performing 
screening method available. Perhaps the most practical overall approach in resource- 
poor settings would be to treat men with symptoms for all three pathogens, and screen 
and treat asymptomatic men (also for all three pathogens) on the basis of a positive 
LED test result.
As indicated above, the current WHO recommendations for the syndromic 
management of men with urethral dischai ge indicate that treatment should only be 
given to men whose complaint of discharge is confirmed on physical examination
[58]. This study suggests that treatment on the basis of symptoms alone, or In 
combination with a positive LED test (without examination), would lead to substantial 
improvements in sensitivity, with only a small decline in specificity. Furthermore, 
current management guidelines do not include dysinia as an entry point for syndromic 
management in men. In this study, 6 of the 20 cases of symptomatic urethi al infection 
would have been missed had men with dysuria (without discharge) been excluded. It
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may be useful therefore to add dysiuia as an entiy point in management guidelines, 
although this would lead to some additional oveilreatment.
It should be noted that no pathogen was identified in about two-thirds of all 
specimens positive by LED testing, and that about one-quaiter of these met laboratory 
criteria for urethiitis (five or more polymorphonuclear cells per high power field on 
urethral swab gram stain). This suggests that either the sensitivity of the diagnostic 
procedures used was less than 100%, or that individuals may have been infected with 
other pathogens. For example, detection of ureaplasma infection was not attempted, 
and it is known that El A testing for C. trachomatis underestimates prevalence [128]. 
Thus, LED performance parameters obtained under the conditions in this study may 
have underestimated its true performance.
STD risk assessment scores, incoiporating demographic, behavioural and 
other characteristics, have been developed for identifying women with cervical 
infection in Zaire [79] and Tanzania [129]. These are potentially useful in many 
developing country settings, where laboratory testing for sexually transmitted 
pathogens is generally unavailable. However, in this study, only recent non­
cohabitation with a spouse was found to be an independent risk factor for N. 
gonorrhoeae and/or C. trachomatis infection. The utility of risk assessment to predict 
urethi'al infection in male populations in developing countries remains to be 
demonstrated.
The key findings of the urethi’al infection study were first the high prevalence 
in general of symptomatic and asymptomatic urethral infection, as well as the 
unexpectedly high prevalence of T. vaginalis, in this population of men in a Kenyan 
workplace. Second, a complaint of urethi al discharge may be a more useflil predictor
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of infection than the sign of discharge on physical examination, and the most useful 
entry point for syndrome-based treatment may be a complaint of discharge and/or 
dysuria. Third, the LED test appears to be a reasonably accurate predictor of infection 
among both symptomatic and asymptomatic men. Finally, risk assessment did not 
prove to be very useful in predicting urethral infection in this population.
The other main group of STDs are those which cause genital ulceration. 
Clinical diagnosis of genital ulcer disease by aetiological agent is umeliable, with one 
American study finding sensitivities of 31% for clinical diagnosis of primary syphilis, 
34% for chancroid and 35% for genital herpes [130]. Another issue which would 
have interfered with the accurate diagnosis of chancroid is that H  ducreyi will only 
survive for 2-4 hours on a swab, unless refrigerated, and it is difficult to culture with a 
sensitivity greater than 80% [131]. It is probable that the sensitivity achieved by the 
swabs taken in the field was lower. A sub-study of 501 HIV-1 seronegative men, 
supervised by Dr Rakwar, found that 26% had antibodies to H ducreyi at em'olment 
[132]. Poor genital hygiene in men is also thought to predispose men to chancroid 
infection [133]. This certainly applies to many of the men in this cohort, who live and 
work in very hot and dirty conditions with limited access to water and privacy for 
bathing and washing clothes. Syphilis was the only other genital ulcer aetiology 
which could be diagnosed in Mombasa, but 50% (65/130) of a sub-group of the men 
had antibodies to Herpes Simplex Type II which also causes genital ulcers, suggesting 
that this was a common infection [132].
Potential treatment strategies, including the use of simple screening tools, such 
as the LED test, need to be further evaluated and ultimately incorporated into 
effective STD control programmes.
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HIV-1 Vaccine Acceptability Issues
A high rate of willingness to participate in candidate prophylactic HIV-1 
vaccine trials was documented in this study of Kenyan trucking company workers. 
Eighty four per cent of men indicated interest in participation. Of concern, however, 
were the disturbing anticipated behaviour changes reported by a significant number of 
respondents. Seventeen percent of men said they would increase sexual risk behaviour 
if involved in a vaccine trial. This occurred despite an intensive individual HIV 
educational counselling programme included in the cohort study and despite having 
been informed in the context of the vaccine survey that half of trial participants would 
receive placebo and half a vaccine of unknown efficacy. This finding underscores the 
need for extensive education both before enrolment of individuals and thr*oughout the 
duration of any vaccine trial.
The successful conduct of HIV-1 vaccine efficacy trials requires the 
availability of cohorts with high seroincidence rates. A number of articles have 
addressed the ethical dilemma which confronts HIV vaccine investigators [134-143]. 
Wliile a high HIV-1 seroincidence permits a trial to be conducted with fewer subjects 
and shorter follow-up, the ethical principles of autonomy and beneficence demand 
that the well- being of the individual participants be maximised by risk reduction 
counselling aimed at reducing the likelihood of HIV-1 acquisition. In the extreme 
case, if  counselling were fully effective in inducing behaviour change and the HIV-1 
seroincidence rate fell markedly, an HIV-1 vaccine trial would not be feasible. 
Although the possibility that participation in a vaccine trial would result in reduced 
HIV-1 seroincidence has been extensively discussed [134-139], less attention has 
been given to the converse. Our study suggests that participation in an HIV-1 vaccine
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trial might be associated with increased risk taking behaviour and therefore possibly 
increased risk of HIV-1 infection. In a study in Rwanda, women participating in 
focus group discussions expressed concern that their seropositive male partners may 
be less likely to use condoms if they knew that the woman was participating in a 
vaccine trial [144]. Females may be particularly vulnerable because of the absence of 
a practical and effective female controlled means of avoiding infection during 
heterosexual intercourse.
Although the process of obtaining consent of participants has become standard 
for biomedical research involving human subjects, special care must be taken to 
ensure that individuals participating in HIV-1 vaccine trials are fully informed of the 
implications of involvement. Counselling must be tailored to each community, 
directed by cultural and language considerations and the level of literacy of the cohort 
and the individual. The concept of a placebo-controlled double-blind trial is not a 
simple one, particularly for poorly educated individuals from communities in which 
the scientific method does not have widespread acceptance.
Another difficult concept which must be conveyed during the consent process 
for HIV-1 vaccine trials is the potential change in serostatus. In a US survey, 84% of 
seronegative intravenous drug users initially said that they would participate in a 
phase III vaccine trial, but this dropped to 41% once it was explained that they would 
test seropositive as a result of participation [145]. In Bangkok, almost half of health 
care providers surveyed were concerned about participation in a vaccine trial if HIV-1 
antibody screening were a routine part of job or health insurance applications[146]. 
HIV antibody tests are increasingly being used for employment or health care 
provision screening purposes in Kenya. Consequently, safeguards against potential
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discrimination for HIV vaccine trial participants would be required. In addition, the 
means of differentiating vaccine induced seropositivity from HIV infection should 
ideally be accessible at the site of the vaccine trial, so that subjects can be informed 
promptly if they become infected.
The evaluation of candidate HIV vaccines will require multiple clinical trials 
in populations which differ according to mode of HIV acquisition, patterns of sexual 
behaviour, exposure to STDs and other transmission cofactors, viral strain type, and 
genetic and nutritional factors which may alter susceptibility. Before this can happen, 
the legitimate concerns of all study populations must be fully addressed.
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Conclusions
The research outlined in this thesis has provided information on the HIV-1 and 
other STD risk in this occupational male cohort in sub-Saliaran Africa, and the 
potential acceptance of HIV-1 prevention inteiwentions. No clear answer to the 
question of whether male circumcision should be recommended as a long-term HIV-1 
prevention strategy was obtained in the research time frame, but information was 
gathered which may assist other investigators. This information has been published in 
international peer-review journals (below), or will be published in the near future.
The most important findings presented in this thesis were:
• The HIV-1 seroincidence of 4% per annum and high level of sexual risk 
behaviour.
• The failure to increase condom use over time, despite active condom promotion, 
high risk perception and a decrease in high-risk sexual contacts.
• The high prevalence of asymptomatic urethral infection, especially Trichomonas 
vaginalis.
• The acceptance of the conditions of an HIV-1 preventive vaccine trial of a high 
percentage of men, but the anticipated negative behaviour change of a minority.
Many of the men who participated in these studies when they were young and 
outwardly healthy are now dead. Their wives and children have lost their source of 
financial support. WHO estimated that six million new HIV-1 infections occuned in 
1997 [11]. Now, at the end of 1998, the need for effective HIV-1 preventive 
interventions has never been greater.
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